SEARCH
Search Details
Shichinohe Hideo
| Hokkaido University Hospital Institute of Health Science Innovation for Medical Care | Professor |
Researcher basic information
■ Degree■ URL
researchmap URL■ Various IDs
J-Global ID■ Research Keywords and Fields
Research Keyword
- Bone marrow stromal cell
- Spinal cord injury
- Differentiation
- Neuroprotection
- Cerebral stroke
- Migration
- 脊髄損傷
- 骨髄間質細胞
- 脳梗塞
- サイトカイン
- 中枢神経再生医療
- PET
- バイオマテリアル
- 光イメージング
- 幹細胞移植
- Regenerative medicine
- Diffuse axonal injury
- 再生医療
- Cerebral infarction
- Functional restoration
- Regeneration
- 機能回復
- transplantation
- 脳挫傷
- 脳損傷
- biomaterial
- 神経再生
- 抗血管新生因子
- Humanities & Social Sciences, Philosophy and ethics, 生命倫理、研究倫理、臨床研究、脳神経倫理学
- Life Science, Neurosurgery, 脳卒中、再生医療
- Master's degree program, Graduate School of Medicine
- Doctoral (PhD) degree program, Graduate School of Medicine
Career
■ CareerCareer
- Apr. 2021 - Present
北海道大学大学院文学研究院, 応用倫理・応用哲学研究教育センター, 研究員 - Apr. 2021 - Present
北海道大学病院, 医療・ヘルスサイエンス研究開発機構 臨床研究監理センター, 准教授 - Jul. 2020 - Present
株式会社RAINBOW, 研究開発担当取締役 - Jan. 2017 - Mar. 2021
北海道大学病院, 臨床研究監理部長, 准教授 - Sep. 2016 - Dec. 2016
北海道大学病院, 臨床研究開発センター, 准教授 - Apr. 2015 - Aug. 2016
北海道大学大学院医学研究科, 脳神経外科, 特任助教 - Feb. 2015 - Aug. 2016
(独) 医薬品医療機器総合機構, 再生医療製品等審査部, 特任職員(非常勤) - Aug. 2010 - Mar. 2015
Hokkaido University, 脳神経外科, 助教
Research activity information
■ Papers- Serial brain FDG-PET and IMZ-SPECT following intracerebral MSC transplantation in patients with subacute ischemic stroke.
Masahito Kawabori; Kenji Hirata; Hideo Shichinohe; Shiro Watanabe; Arisa Miura; Yoichi M Ito; Kohsuke Kudo; Satoshi Kuroda; Kiyohiro Houkin; Miki Fujimura
Stem cell research & therapy, 12 May 2026, [International Magazine]
English, Scientific journal, Ischemic stroke is a leading cause of mortality and long-term neurological disability worldwide, and cell-based therapies represent a promising approach. Although clinical studies have reported favorable outcomes following cell transplantation, the effects on host neuronal integrity remain incompletely understood. This study investigated temporal and spatial changes in fluorodeoxyglucose positron emission tomography (FDG-PET) and 123I-iomazenil single-photon emission computed tomography (IMZ-SPECT) after intracerebral cell transplantation in patients with subacute ischemic stroke and examined their relationship with functional recovery. Seven adults with severe post-stroke disability underwent autologous mesenchymal stromal cell (HUNS001-01) transplantation 47-64 days after stroke onset. Brain FDG-PET and IMZ-SPECT were performed preoperatively and at 1, 3, and 12 months post-transplantation. Regions of interest were first manually set in the ipsilateral cortex where the 12-month postoperative-to-preoperative standard uptake value ratio seems increased, and followed by quantitative measurement. Five of seven patients demonstrated 5% or more increase of FDG-PET and/or IMZ-SPECT uptake in peri-infarct cortical regions, predominantly within the frontal or temporal cortex. Transplanted cells localized either within metabolically enhanced regions or in anatomically remote areas. FDG-PET and IMZ-SPECT changes were strongly interacted in each other and were associated with functional improvement. Overall, improvement of glucose metabolism and synaptic density/viability were observed in patient with subacute ischemic stroke, which may have been attributable to cell transplantation.Trial registration: UMIN000026130. - Phase I/II trial of intracerebral transplantation of autologous bone marrow stem cells combined with recombinant peptide scaffold for patients with chronic intracerebral haemorrhage: a study protocol.
Masahito Kawabori; Hideo Shichinohe; Kaoru Kahata; Arisa Miura; Kenichiro Maeda; Yoichi M Ito; Masahiko Mukaino; Ryo Kogawa; Kentaro Nakamura; Shuho Gotoh; Kota Kurisu; Miki Fujimura
BMJ open, 14, 12, e083959, 02 Dec. 2024, [International Magazine]
English, Scientific journal, INTRODUCTION: Intracerebral haemorrhage (ICH) stands as a leading global cause of death and disability, posing a significant challenge with limited treatment options, especially for chronic patients. Recent advances in stem cell therapies have opened new avenues for therapeutic potential. Our previous preclinical research has demonstrated that intracerebral transplantation of bone marrow stromal cells (BMSCs) combined with a recombinant human collagen type I scaffold enables higher cell survival and engraftment and holds promising potential. In this article, we present the protocol for a novel clinical trial, named 'Research on Advanced Intervention using Novel Bone MarrOW stem cells for chronic intracerebral haemorrhage' (RAINBOW-Hx). METHODS AND ANALYSIS: RAINBOW-Hx is a phase I/II, open-label, uncontrolled study with the primary objective of assessing the safety and efficacy of intracerebral transplantation of autologous BMSCs combined with the scaffold (HUFF-01) in patients with chronic ICH. Eight patients, experiencing moderate to severe neurological deficits for 12 months or longer, will be enrolled. The haemorrhage location will be limited to the basal ganglia and thalamus. Approximately 50 mL of bone marrow will be extracted from the iliac bone of each patient, and BMSCs will be cultured using autologous platelet lysate. 3 days before transplantation, BMSCs will be combined with the scaffold to generate HUFF-01. Each patient will receive a 50 000 HUFF-01 dose, containing approximately 50 million BMSCs, through stereotactic transplantation into the haemorrhagic cavity. Neurological assessments, MRI, 18F-fluorodeoxyglucose positron emission tomography and 123I-Iomazenil single-photon emission CT will be performed for 1 year after administration. ETHICS AND DISSEMINATION: The trial protocols were reviewed and approved by the Institutional Review Board of the Hokkaido University Hospital (R5-11), and this study is conducted according to Good Clinical Practice guidelines and the principles of the Declaration of Helsinki. The results of this trial will be submitted for publication in a peer-reviewed scientific journal. TRIAL REGISTRATION NUMBER: jRCT2013230053, Japan Registry of Clinical Trials. - Intracerebral transplantation of MRI-trackable autologous bone marrow stromal cells for patients with subacute ischemic stroke.
Masahito Kawabori; Satoshi Kuroda; Hideo Shichinohe; Kaoru Kahata; Souichi Shiratori; Satoshi Ikeda; Taisuke Harada; Kenji Hirata; Khin Khin Tha; Masato Aragaki; Shunsuke Terasaka; Yoichi M Ito; Naoki Nishimoto; Shunsuke Ohnishi; Ichiro Yabe; Kohsuke Kudo; Kiyohiro Houkin; Miki Fujimura
Med (New York, N.Y.), 18 Mar. 2024, [International Magazine]
English, Scientific journal, BACKGROUND: Ischemic stroke is one of the leading causes of death and neurological disability worldwide, and stem cell therapy is highly expected to reverse the sequelae. This phase 1/2, first-in-human study evaluated the safety, feasibility, and monitoring of an intracerebral-transplanted magnetic resonance imaging (MRI)-trackable autologous bone marrow stromal cell (HUNS001-01) for patients with subacute ischemic stroke. METHODS: The study included adults with severe disability due to ischemic stroke. HUNS001-01 cultured with human platelet lysates and labeled with superparamagnetic iron oxide was stereotactically transplanted into the peri-infarct area 47-64 days after ischemic stroke onset (dose: 2 or 5 × 107 cells). Neurological and radiographic evaluations were performed throughout 1 year after cell transplantation. The trial was registered at UMIN Clinical Trial Registry (number UMIN000026130). FINDINGS: All seven patients who met the inclusion criteria successfully achieved cell expansion, underwent intracerebral transplantation, and completed 1 year of follow-up. No product-related adverse events were observed. The median National Institutes of Health Stroke Scale and modified Rankin scale scores before transplantation were 13 and 4, which showed improvements of 1-8 and 0-2, respectively. Cell tracking proved that the engrafted cells migrated toward the infarction border area 1-6 months after transplantation, and the quantitative susceptibility mapping revealed that cell signals at the migrated area constantly increased throughout the follow-up period up to 34% of that of the initial transplanted site. CONCLUSIONS: Intracerebral transplantation of HUNS001-01 was safe and well tolerated. Cell tracking shed light on the therapeutic mechanisms of intracerebral transplantation. FUNDING: This work was supported by the Japan Agency for Medical Research and Development (AMED; JP17bk0104045 and JP20bk0104011). - Intracerebral Transplantation of Mesenchymal Stromal Cell Compounded with Recombinant Peptide Scaffold against Chronic Intracerebral Hemorrhage Model
Soichiro Takamiya; Masahito Kawabori; Tsukasa Kitahashi; Kentaro Nakamura; Yuki Mizuno; Hironobu Yasui; Yuji Kuge; Aki Tanimori; Yasuyuki Takamatsu; Kohei Yuyama; Hideo Shichinohe; Miki Fujimura
Stem Cells International, 2022, 1, 10, Hindawi Limited, 31 Jul. 2022
Scientific journal, Background. Due to the lack of effective therapies, stem cell transplantation is an anticipated treatment for chronic intracerebral hemorrhage (ICH), and higher cell survival and engraftment are considered to be the key for recovery. Mesenchymal stromal cells (MSCs) compounded with recombinant human collagen type I scaffolds (CellSaics) have a higher potential for cell survival and engraftment compared with solo-MSCs, and we investigated the validity of intracerebral transplantation of CellSaic in a chronic ICH model. Methods. Rat CellSaics (rCellSaics) were produced by rat bone marrow-derived MSC (rBMSCs). The secretion potential of neurotrophic factors and the cell proliferation rate were compared under oxygen-glucose deprivation (OGD) conditions. rCellSaics, rBMSCs, or saline were transplanted into the hollow cavity of a rat chronic ICH model. Functional and histological analyses were evaluated, and single-photon emission computed tomography for benzodiazepine receptors was performed to monitor sequential changes in neuronal integrity. Furthermore, human CellSaics (hCellSaics) were transplanted into a chronic ICH model in immunodeficient rats. Antibodies neutralizing brain-derived neurotrophic factor (BDNF) were used to elucidate its mode of action. Results. rCellSaics demonstrated a higher secretion potential of trophic factors and showed better cell proliferation in the OGD condition. Animals receiving rCellSaics displayed better neurological recovery, higher intracerebral BDNF, and better cell engraftment; they also showed a tendency for less brain atrophy and higher benzodiazepine receptor preservation. hCellSaics also promoted significant functional recovery, which was reversed by BDNF neutralization. Conclusion. Intracerebral transplantation of CellSaics enabled neurological recovery in a chronic ICH model and may be a good option for clinical application. - Intracerebral Transplantation of Autologous Bone Marrow Stem Cell (BMSC) for Subacute Ischemic Stroke, Phase 1 Clinical Trial (RAINBOW Trial)
Masahito Kawabori; Hideo Shichinohe; Satoshi Kuroda; Kiyohiro Houkin
STROKE, 52, Mar. 2021, [Peer-reviewed]
English - Corrigendum to "Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease".
Masahito Kawabori; Aki Tanimori; Shinri Kitta; Hideo Shichinohe; Kiyohiro Houkin
Stem cells international, 2021, 9796010, 9796010, 2021, [Peer-reviewed], [International Magazine]
English, Scientific journal - 脳梗塞に対する新規治療の開発-血栓回収療法時代のアンメットメディカルニーズと医薬品開発戦略- 主幹動脈閉塞脳梗塞患者に対する幹細胞脳内移植治験(RAINBOW研究)
川堀 真人; 七戸 秀夫; 黒田 敏; 宝金 清博
脳循環代謝, 32, 1, 52, 52, (一社)日本脳循環代謝学会, Nov. 2020
Japanese - 脳梗塞急性期患者への自家BMSC脳内投与による再生治療(Phase 1)とPhase 2に向けた取り組み
川堀 真人; 七戸 秀夫; 黒田 敏; 宝金 清博
脳循環代謝, 32, 1, 60, 60, (一社)日本脳循環代謝学会, Nov. 2020
Japanese - 脳神経細胞治療・遺伝子治療の実践 脳出血慢性期モデルに対する骨髄幹細胞+足場材製剤(CellSaic)の有効性
高宮 宗一朗; 川堀 真人; 七戸 秀夫; 中村 健太郎; 北橋 宗; 岩澤 玲子; 古川 友子; 宝金 清博
脳循環代謝, 32, 1, 68, 68, (一社)日本脳循環代謝学会, Nov. 2020
Japanese - Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke.
Masahito Kawabori; Hideo Shichinohe; Satoshi Kuroda; Kiyohiro Houkin
International journal of molecular sciences, 21, 19, 06 Oct. 2020, [International Magazine]
English, Scientific journal, Despite recent developments in innovative treatment strategies, stroke remains one of the leading causes of death and disability worldwide. Stem cell therapy is currently attracting much attention due to its potential for exerting significant therapeutic effects on stroke patients. Various types of cells, including bone marrow mononuclear cells, bone marrow/adipose-derived stem/stromal cells, umbilical cord blood cells, neural stem cells, and olfactory ensheathing cells have enhanced neurological outcomes in animal stroke models. These stem cells have also been tested via clinical trials involving stroke patients. In this article, the authors review potential molecular mechanisms underlying neural recovery associated with stem cell treatment, as well as recent advances in stem cell therapy, with particular reference to clinical trials and future prospects for such therapy in treating stroke. - Responses of immune organs following cerebral ischemic stroke.
Chengbo Tan; Zifeng Wang; Miao Zheng; Songji Zhao; Hideo Shichinohe; Kiyohiro Houkin
Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 88, 3, 228, 237, 31 Aug. 2020, [Domestic magazines]
English, Scientific journal, BACKGROUND: Stroke is a leading cause of death and disability worldwide. Recently, brain secondary damage has been hypothesized to be a key aggravating element in an ischemic cascade. However, the interaction between cerebral infarction and immune organs has yet to be fully understood. In this study, we investigated the changes in the rat brain, spleen, thymus, mesenteric lymph node, and liver at 3, 7, and 13 days after transient middle cerebral artery occlusion (tMCAO) by immunohistochemistry. MATERIAL AND METHODS: Rat models of stroke were made by tMCAO. Functional assessment was performed 3 h, and 1, 3, 5, 7, 9, 11, and 13 days after MCAO. Rat organs were harvested for 2,3,5-triphenyltetrazolium chloride staining and Immunohistochemistry. RESULTS: The CD8α+ T cells was found to decrease in the spleen, thymus, mesenteric lymph node, and liver, whereas it increased in the brain. Those of Iba1+ and CD68+ macrophages were decreased in the spleen, thymus, and mesenteric lymph node, whereas they were elevated in the brain and liver. Ki67+ cells showed the same characteristics as macrophages, and increased numbers of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive apoptotic cells were found in the spleen, mesenteric lymph node, liver, and brain. CONCLUSIONS: The present results demonstrated that stroke is a systemic disease, which not only affects the brain, but also induces responses of immune organs. On the basis of these results, a systemic treatment might be a good strategy for clinical stroke care. - 【放射線科医が知っておくべき 脳血管障害診療 update】脳血管障害に対する再生医療・細胞治療の現状と今後の展望
川堀 真人; 七戸 秀夫; 黒田 敏; 寳金 清博
臨床画像, 36, 4月増刊, 141, 150, (株)メジカルビュー社, Apr. 2020, [Peer-reviewed]
Japanese - Evaluation of Novel Stereotactic Cannula for Stem Cell Transplantation against Central Nervous System Disease.
Masahito Kawabori; Aki Tanimori; Shinri Kitta; Hideo Shichinohe; Kiyohiro Houkin
Stem cells international, 2020, 4085617, 4085617, 2020, [Peer-reviewed], [International Magazine]
English, Cell therapy for central nervous system (CNS) disorders is beginning to prove its safety and efficiency. Intraparenchymal transplantation can be an option for cell delivery; however, one concern regarding this method is that the transplantation cannula may cause additional brain injuries. These include vessel damage, which results in brain hemorrhage, and clogging of the cannula by brain debris and/or cell clusters, which requires replacement of the cannula or forced injection causing jet flow of the cell suspension. We compared cannulas for cell delivery used in clinical trials, the Pittsburg and Mizuho cannulas, to a newly designed one, MK01, to assess their usability. MK01 has a spherical-shaped tip with a fan-like open orifice on the side of the cannula, which prevents vessel damage, clogging of brain debris, and jet flow phenomenon. We compared the extent of rat cervical and abdominal arterial damage with the cannula, the amount of debris in the cannula, the force needed to cause jet flow, and cell viability. While the viability of cells passed through the cannulas was almost the same among cannulas (approximately 95%), the Pittsburg cannula caused cervical arterial injury and subsequent hemorrhage, as it required a significantly smaller force to penetrate the arterial wall. Moreover, the Pittsburg cannula, but not the Mizuho and MK01 cannulas, showed high frequency of brain debris in the needle tip (approximately 80%) after brain puncture. While jet flow of the injection liquid was observed even when using smaller forces in the Pittsburg and Mizuho cannulas, MK01 constantly showed low jet flow occurrence. Thus, MK01 seems to be safer than the previously reported cannulas, although further investigation is necessary to validate its safety for clinical use. - 脳梗塞亜急性期に対する自家骨髄間質細胞の脳内投与 第一相治験:RAINBOW研究
川堀 真人; 七戸 秀夫; 黒田 敏; 寳金 清博
脳循環代謝, 31, 1, 83, 83, (一社)日本脳循環代謝学会, Nov. 2019, [Peer-reviewed]
Japanese - 【脳卒中-診断・治療の最新動向-】基礎研究 脳卒中患者に対する細胞移植・再生医療の現状と将来
川堀 真人; 七戸 秀夫; 黒田 敏; 宝金 清博
日本臨床, 77, 6, 945, 953, (株)日本臨床社, Jun. 2019
Japanese - 脳梗塞亜急性期に対する自家骨髄幹細胞の直接投与(第一相治験:RAINBOW研究)
川堀 真人; 七戸 秀夫; 黒田 敏; 寳金 清博
神経治療学, 36, 6, S128, S128, 日本神経治療学会, 2019
Japanese - [18F]DPA-714 PET imaging shows immunomodulatory effect of intravenous administration of bone marrow stromal cells after transient focal ischemia.
Tan C; Zhao S; Higashikawa K; Wang Z; Kawabori M; Abumiya T; Nakayama N; Kazumata K; Ukon N; Yasui H; Tamaki N; Kuge Y; Shichinohe H; Houkin K
EJNMMI research, 8, 1, 35, 35, May 2018, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: The potential application of bone marrow stromal cell (BMSC) therapy in stroke has been anticipated due to its immunomodulatory effects. Recently, positron emission tomography (PET) with [18F]DPA-714, a translocator protein (TSPO) ligand, has become available for use as a neural inflammatory indicator. We aimed to evaluate the effects of BMSC administration after transient middle cerebral artery occlusion (MCAO) using [18F]DPA-714 PET. The BMSCs or vehicle were administered intravenously to rat MCAO models at 3 h after the insult. Neurological deficits, body weight, infarct volume, and histology were analyzed. [18F]DPA-714 PET was performed 3 and 10 days after MCAO. RESULTS: Rats had severe neurological deficits and body weight loss after MCAO. Cell administration ameliorated these effects as well as the infarct volume. Although weight loss occurred in the spleen and thymus, cell administration suppressed it. In both vehicle and BMSC groups, [18F]DPA-714 PET showed a high standardized uptake value (SUV) around the ischemic area 3 days after MCAO. Although SUV was increased further 10 days after MCAO in both groups, the increase was inhibited in the BMSC group, significantly. Histological analysis showed that an inflammatory reaction occurred in the lymphoid organs and brain after MCAO, which was suppressed in the BMSC group. CONCLUSIONS: The present results suggest that BMSC therapy could be effective in ischemic stroke due to modulation of systemic inflammatory responses. The [18F]DPA-714 PET/CT system can accurately demonstrate brain inflammation and evaluate the BMSC therapeutic effect in an imaging context. It has great potential for clinical application. - Accelerating Cell Therapy for Stroke in Japan: Regulatory Framework and Guidelines on Development of Cell-Based Products.
Houkin K; Shichinohe H; Abe K; Arato T; Dezawa M; Honmou O; Horie N; Katayama Y; Kudo K; Kuroda S; Matsuyama T; Miyai I; Nagata I; Niizuma K; Sakushima K; Sasaki M; Sato N; Sawanobori K; Suda S; Taguchi A; Tominaga T; Yamamoto H; Yamashita T; Yoshimine T; Working Group; for Guidelines on Development of Cell-Based; Products for the Treatment of Cerebral Infarction
Stroke, 49, 4, e145, e152, Apr. 2018, [Peer-reviewed] - Human Recombinant Peptide Sponge Enables Novel, Less Invasive Cell Therapy for Ischemic Stroke.
Miyamoto M; Nakamura K; Shichinohe H; Yamauchi T; Ito M; Saito H; Kawabori M; Osanai T; Sasaki T; Houkin K; Kuroda S
Stem cells international, 2018, 4829534, 4829534, 2018, [Peer-reviewed], [International Magazine]
English, Scientific journal, Bone marrow stromal cell (BMSC) transplantation has the therapeutic potential for ischemic stroke. However, it is unclear which delivery routes would yield both safety and maximal therapeutic benefits. We assessed whether a novel recombinant peptide (RCP) sponge, that resembles human collagen, could act as a less invasive and beneficial scaffold in cell therapy for ischemic stroke. BMSCs from green fluorescent protein-transgenic rats were cultured and Sprague-Dawley rats were subjected to permanent middle cerebral artery occlusion (MCAo). A BMSC-RCP sponge construct was transplanted onto the ipsilateral intact neocortex 7 days after MCAo. A BMSC suspension or vehicle was transplanted into the ipsilateral striatum. Rat motor function was serially evaluated and histological analysis was performed 5 weeks after transplantation. The results showed that BMSCs could proliferate well in the RCP sponge and the BMSC-RCP sponge significantly promoted functional recovery, compared with the vehicle group. Histological analysis revealed that the RCP sponge provoked few inflammatory reactions in the host brain. Moreover, some BMSCs migrated to the peri-infarct area and differentiated into neurons in the BMSC-RCP sponge group. These findings suggest that the RCP sponge may be a promising candidate for animal protein-free scaffolds in cell therapy for ischemic stroke in humans. - Superior Microvascular Perfusion of Infused Liposome-Encapsulated Hemoglobin Prior to Reductions in Infarctions after Transient Focal Cerebral Ischemia
Daisuke Shimbo; Takeo Abumiya; Kota Kurisu; Toshiya Osanai; Hideo Shichinohe; Naoki Nakayama; Ken Kazumata; Hideki Nakamura; Hiroshi Shimuzu; Kiyohiro Houkin
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 26, 12, 2994, 3003, Dec. 2017, [Peer-reviewed]
English, Scientific journal - Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke
Hideo Shichinohe; Masahito Kawabori; Hiroaki Iijima; Tuyoshi Teramoto; Takeo Abumiya; Naoki Nakayama; Ken Kazumata; Shunsuke Terasaka; Teruyo Arato; Kiyohiro Houkin
BMC NEUROLOGY, 17, 1, 179, Sep. 2017, [Peer-reviewed]
English, Scientific journal - Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease
Ken Kazumata; Khin Khin Tha; Haruto Uchino; Tohru Shiga; Hideo Shichinohe; Masaki Ito; Naoki Nakayama; Takeo Abumiya
JOURNAL OF NEUROSURGERY, 127, 2, 260, 269, Aug. 2017, [Peer-reviewed]
English, Scientific journal - Surgical Outcome of Cerebral Aneurysm Clipping Treated with Immunosuppressants: Report of 11 Cases and Review of the Literature
Masaaki Hokari; Naoki Nakayama; Ken Kazumata; Toshiya Osanai; Hideo Shichinohe; Takeo Abumiya; Kiyohiro Houkin
NEUROLOGIA MEDICO-CHIRURGICA, 57, 3, 122, 127, Mar. 2017, [Peer-reviewed]
English, Scientific journal - Application of cell sheet technology to bone marrow stromal cell transplantation for rat brain infarct
Masaki Ito; Hideo Shichinohe; Kiyohiro Houkin; Satoshi Kuroda
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 11, 2, 375, 381, Feb. 2017, [Peer-reviewed]
English, Scientific journal - Functional bio-imaging
Hisayasu Saito; Michiyuki Miyamoto; Hideo Shichinohe; Kiyohiro Houkin; Satoshi Kuroda
Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials, 111, 119, Springer Japan, 01 Jan. 2017, [Peer-reviewed]
English, In book - Cell therapy for ischemic stroke with bone marrow stromal cells
Satoshi Kuroda; Hideo Shichinohe; Kiyohiro Houkin
Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials, 15, 25, Springer Japan, 01 Jan. 2017, [Peer-reviewed]
English, In book - Ultrasound-guided Femoral Artery Access for Minimally Invasive Neuro-intervention and Risk Factors for Access Site Hematoma.
Kurisu K; Osanai T; Kazumata K; Nakayama N; Abumiya T; Shichinohe H; Shimoda Y; Houkin K
Neurologia medico-chirurgica, 56, 12, 745, 752, Dec. 2016, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Although ultrasound (US) guidance for venous access is becoming the "standard of care" for preventing access site complications, its feasibility for arterial access has not been fully investigated, especially in the neuro-interventional population. We conducted the first prospective cohort study on US-guided femoral artery access during neuro-interventional procedure. This study included 64 consecutive patients who underwent US-guided femoral artery access through 66 arterial access sites for diagnostic and/or neuro-interventional purposes. The number of attempts required for both the sheath insertion and the success of anterior wall puncture were recorded. In addition, the occurrence of major complications and hematoma formation on the arterial access site examined by US were statistically analyzed. The median number of attempts was 1 (1-2) and first-pass success rate was 63.6%. Anterior wall puncture was achieved in 98.5%. In one case (1.5%), a pseudoaneurysm was observed. In all cases, US clearly depicted a common femoral artery (CFA) and its bifurcation. Post-procedural hematoma was detected in 13 cases (19.7%), most of which were "tiny" or "moderate" in size. Low body mass index and antiplatelet therapy were the independent risk factors for access site hematoma. The US-guided CFA access was feasible even in neuro-interventional procedure. The method was particularly helpful in the patients with un-palpable pulsation of femoral arteries. To prevent arterial access site hematoma, special care should be taken in patients with low body mass index and who are on antiplatelet therapy. - Increased Blood Viscosity in Ischemic Stroke Patients with Small Artery Occlusion Measured by an Electromagnetic Spinning Sphere Viscometer.
Furukawa K; Abumiya T; Sakai K; Hirano M; Osanai T; Shichinohe H; Nakayama N; Kazumata K; Hida K; Houkin K
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 25, 11, 2762, 2769, Elsevier, Nov. 2016, [Peer-reviewed]
English, Background and Purpose: High blood viscosity causes blood stagnation and subsequent pathological thrombotic events, resulting in the development of ischemic stroke. We hypothesize that the contribution of blood viscosity may differ among ischemic stroke subtypes based on specific pathological conditions. We tried to verify this hypothesis by measuring blood viscosity in acute ischemic stroke patients using a newly developed electromagnetic spinning sphere (EMS) viscometer. Methods: Measurements in acute ischemic stroke patients were performed 4 times during admission and data were compared with those obtained from 100 healthy outpatient volunteers. Results: We enrolled 92 patients (cardioembolism [CE]: 25, large-artery atherosclerosis [LAA]: 42, and small artery occlusion [SAO]: 25) in this study. Comparisons of blood viscosity between the ischemic stroke subgroups and control group revealed that blood viscosity at the date of admission was significantly higher in the SAO group (5.37±1.11 mPa・s) than in the control group (4.66±0.72 mPa・s) (p<0.01). Among all subtype groups showing a reduction in blood viscosity after 2 weeks, the SAO group showed the highest and most significant reduction, indicating that SAO patients had the most concentrated blood at the onset. Conclusions: Blood viscosity was significantly increased in the SAO group at the date of admission, which indicated the contribution of dehydration to the onset of ischemic stroke. The importance of dehydration needs to be emphasized more in the pathogenesis of SAO. The clinical application of the EMS viscometer is promising for understanding and differentiating the pathogenesis of ischemic stroke. - Transarterial regional hypothermia provides robust neuroprotection in a rat model of permanent middle cerebral artery occlusion with transient collateral hypoperfusion.
Kurisu K; Abumiya T; Ito M; Gekka M; Osanai T; Shichinohe H; Nakayama N; Kazumata K; Houkin K
Brain research, 1651, 95, 103, Nov. 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal, The robust neuroprotective effects of transarterial regional hypothermia have been demonstrated in the typical transient middle cerebral artery occlusion (tMCAO) model, but have not yet been tested in other ischemic stroke models, even though clinical ischemic conditions are diverse. In order to clarify these effects in a different ischemic stroke model, we employed a rat model of permanent MCAO (pMCAO) with transient collateral hypoperfusion (tCHP), which was achieved by direct MCA ligation through craniotomy and 1-h bilateral common carotid artery occlusion at the beginning of pMCAO. The infusion of 20ml/kg of 4°C cold saline (CS) or 37°C warm saline (WS) into the ipsilateral internal carotid artery (ICA) was performed for 15min in intra- or post-tCHP. Neurological scores, infarct/edema volumes, and neuronal apoptosis and reactive gliosis were compared between the CS and WS groups and a non-infusion control group after 48h of reperfusion. Although brain temperatures were only reduced by 2-3°C for 15min, the CS group had significantly better neurological scores, smaller infarct/edema volumes, and less penumbral neuronal apoptosis and reactive gliosis than the control and WS groups. The post-tCHP CS group exhibited prominent neuroprotective effects, even though infarct volumes and neuronal apoptosis were reduced less than those in the intra-tCHP CS group. In conclusion, we demonstrated the neuroprotective effects of transarterial regional hypothermia in an ischemic model of pMCAO with tCHP. Even though MCAO is persistent, cold infusion via the ICA is neuroprotective for the penumbra, suggesting the wider therapeutic application of this therapy. - Cell Therapy for Stroke: Review of Previous Clinical Trials and Introduction of Our New Trials.
Shichinohe H; Houkin K
Neurologia medico-chirurgica, 56, 10, 592, 596, Oct. 2016, [Peer-reviewed], [Domestic magazines]
English, Scientific journal, Stroke is still a leading cause of death and disability, and despite intensive research, few treatment options exist. A recent breakthrough in cell therapy is expected to reverse the neurological sequelae of stroke. Although some pioneer studies on the use of cell therapy for the treatment of stroke have been reported, certain problems still remain unsolved. We investigated the use of autologous bone marrow stromal cell (BMSC) transplantation for the treatment of stroke, to develop it as the next-generation cell therapy. In this study, we introduce the preparation of a new clinical trial, the Research on Advanced Intervention using Novel Bone marrow stem cell (RAINBOW) study. The trial will start in 2016, and we hope that it will not only be helpful for treating patients but also for clarifying the therapeutic mechanisms. Moreover, we review stem cell therapeutics as an emerging paradigm in stroke (STEPS) and the guidelines for the development of cell therapy for stroke in the United States as well as introduce the development of new guidelines in Japan. These guidelines are expected to encourage the development of cell therapy for stroke management. - Measurement of human blood viscosity by an electromagnetic spinning sphere viscometer.
Furukawa K; Abumiya T; Sakai K; Hirano M; Osanai T; Shichinohe H; Nakayama N; Kazumata K; Aida T; Houkin K
Journal of medical engineering & technology, 40, 6, 285, 292, Aug. 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal, We herein applied an electromagnetic spinning sphere (EMS) viscometer to the measurement of human blood viscosity for the first time. We collected blood samples from 100 healthy outpatient volunteers in order to analyse viscosity dependence on blood cell parameters and on the shear rate with a simple approximation formula [ηi (γ)\, = Ai γ(- pi) + η0]. Viscosity dependence on blood cell parameters was relatively high at a high shear rate, but became lower as the shear rate decreased. The approximation formula with appropriate parameters of Ai and pi nearly faithfully reproduced actual blood rheological behaviour with a standard deviation of 1.5%. The distributions of Ai and pi values were broad, suggesting that the pattern of viscosity dependence on the shear rate varied with individual differences. The results obtained using the EMS viscometer suggest that blood viscosity values are individual-specific and actual individual measurements are important for understanding rheological conditions. - Transarterial Regional Brain Hypothermia Inhibits Acute Aquaporin-4 Surge and Sequential Microvascular Events in Ischemia/Reperfusion Injury.
Kurisu K; Abumiya T; Nakamura H; Shimbo D; Shichinohe H; Nakayama N; Kazumata K; Shimizu H; Houkin K
Neurosurgery, 79, 1, 125, 134, Jul. 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: Although transarterial regional hypothermia is an attractive alternative to general hypothermia, its efficacy and underlying mechanisms remain unclear. OBJECTIVE: To confirm transarterial regional hypothermia therapeutic effects on ischemia/reperfusion (I/R) injury and to elucidate the mechanisms responsible. METHODS: The therapeutic effects of transarterial regional hypothermia were initially investigated in 2-hour middle cerebral artery occlusion rats regionally infused with 10°C saline (cold saline group) or 37°C saline (warm saline group) and untreated rats (control group) just before the onset of 24 hours of reperfusion. The time course of infarct and edema progression, inflammatory reactions, microvascular morphological changes, and aquaporin-4 (AQP4) expression was analyzed after 0, 2, 6, and 24 hours of reperfusion. RESULTS: Cold saline infusion only lowered brain temperatures for 30 minutes but mediated strong neuroprotective effects with infarct volume reductions of less than one-third. The time-course analysis revealed the following sequence of ischemia/reperfusion injury-related events in the control group: upregulated expression of AQP4 (2 hours); microvascular narrowing resulting from swollen astrocytic end-feet (2-6 hours); infarct and edema progression, blood-brain barrier disruption, and upregulated expression of intracellular adhesion molecule-1 (6-24 hours); and the activation of other inflammatory reactions (24 hours). These sequential events were inhibited in the cold saline group. CONCLUSION: Transarterial regional hypothermia initially inhibited the acute AQP4 surge and then attenuated microvascular narrowing, blood-brain barrier disruption, and activation of other inflammatory reactions, leading to strong neuroprotective effects. More direct and intensive cooling of the endothelium and its surroundings may contribute to these effects. ABBREVIATIONS: AQP4, aquaporin-4BBB, blood-brain barrierIba1, ionized calcium-binding adapter molecule 1ICA, internal carotid arteryICAM-1, intracellular adhesion molecule-1I/R, ischemia/reperfusionMCAO, middle cerebral artery occlusionMMP-9, matrix metalloproteinase-9. - Investigating Brain Network Characteristics Interrupted by Covert White Matter Injury in Patients with Moyamoya Disease: Insights from Graph Theoretical Analysis
Kazumata K; Tha K.K; Narita H; Shichinohe H; Ito M; Uchino H; Abumiya T
World Neurosurgery, 89, 654, 665.e2, May 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal - De novo arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia.
Shimoda Y; Osanai T; Nakayama N; Ushikoshi S; Hokari M; Shichinohe H; Abumiya T; Kazumata K; Houkin K
Journal of neurosurgery. Pediatrics, 17, 3, 330, 335, Mar. 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal, Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant systemic disorder characterized by the enlargement of capillaries, recurrent nosebleeds, and multiple arteriovenous malformations (AVMs). Although cerebral AVMs are traditionally considered to be congenital lesions, some reports have described de novo AVMs, which suggests that the authors believed them to be dynamic conditions. In this article, the authors describe the case of a 5-year-old boy with HHT in whom a de novo cerebral AVM was detected after a negative MRI result at 5 months. To the authors' knowledge, this is the first report of a de novo AVM in a patient with HHT. In patients with a family history of HHT, de novo AVMs are possible, even when no lesions are detected at the first screening. Therefore, regular screenings need to be performed, and the family should be informed that AVMs could still develop despite normal MRI results. - A Novel Large Cerebral Aneurysm Model in Rats with Intraperitoneal Administration of Beta-Amino Propio Nitril-Fumarate.
Shimoda Yusuke; Moriwaki Takuya; Nakayama Naoki; Abumiya Takeo; Kazumata Ken; Shichinohe Hideo; Houkin Kiyohiro
STROKE, 47, Feb. 2016, [Peer-reviewed] - New Clinical Application of Measurement of Blood Viscosity With an Electromagnetically Spinning Sphere Viscometer in Acute Ischemic Stroke Patients
Abumiya Takeo; Furukawa Koji; Sakai Keiji; Hirano Miki; Osanai Toshiya; Shichinohe Hideo; Nakayama Naoki; Kazumata Ken; Aida Toshimitsu; Houkin Kiyohiro
STROKE, 47, Feb. 2016, [Peer-reviewed] - The Next Generation of Autologous Bone Marrow Stromal Cell Transplantation Against Stroke
Shichinohe Hideo; Tan Chengbo; Saito Hisayasu; Miyamoto Michiyuki; Hamauchi Shuji; Abumiya Takeo; Nakayama Naoki; Kazumata Ken; Houkin Kiyohiro; Kuroda Satoshi
STROKE, 47, Feb. 2016, [Peer-reviewed] - Trans-arterial Regional Hypothermia Provides Robust Neuroprotection in Rat Permanent Middle Cerebral Artery Occlusion Model
Kurisu Kota; Abumiya Takeo; Ito Masaki; Shichinohe Hideo; Nakayama Naoki; Kazumata Ken; Osanai Toshiya; Houkin Kiyohiro
STROKE, 47, Feb. 2016, [Peer-reviewed] - Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke
Chengbo Tan; Hideo Shichinohe; Zifeng Wang; Shuji Hamauchi; Takeo Abumiya; Naoki Nakayama; Ken Kazumata; Tsuneo Ito; Kohsuke Kudo; Shigeru Takamoto; Kiyohiro Houkin
Stem Cells International, 2016, Hindawi Limited, 2016, [Peer-reviewed]
English, Scientific journal - [Efficacy of Stent-Assisted Coil Embolization for a Dissecting Aneurysm of the Cervical Internal Carotid Artery Caused by a Systemic Vascular Disease: A Case Report].
Takamiya S; Osanai T; Ushikoshi S; Kurisu K; Shimoda Y; Ito Y; Ishi Y; Hokari M; Nakayama N; Kazumata K; Abumiya T; Shichinohe H; Houkin K
No shinkei geka. Neurological surgery, 44, 1, 39, 45, Jan. 2016, [Peer-reviewed], [Domestic magazines]
Japanese, Scientific journal, Systemic vascular diseases such as fibromuscular dysplasia, Ehlers-Danlos syndrome, Marfan syndrome, and Behçet's disease are known to cause spontaneous dissecting aneurysms of the cervical internal carotid artery. These diseases are generally associated with vascular fragility; therefore, invasive treatments are avoided in many cases of dissecting aneurysms, and a conservative approach is used for the primary disease. Surgical or intravascular treatment may be chosen when aneurysms are progressive or are associated with a high risk of hemorrhage; however, there is no consensus on which treatment is better. We report a case of a dissecting aneurysm of the cervical internal carotid artery in a patient with suspected Behçet's disease, which was treated using stent-assisted coil embolization. A man in his 40's, with suspected Behçet's disease, presented with an enlarged dissecting aneurysm of the right cervical internal carotid artery. The lesion was present for approximately 10 years. We performed stent-assisted coil embolization for the lesion. Post-surgery, no aneurysms were detected with carotid artery echography. Our case report suggests that stent-assisted coil embolization is a promising treatment for dissecting aneurysms of the cervical internal carotid artery. In addition, the procedure demonstrates the utility of carotid artery echograms for examining recanalization after stent-assisted coil embolization. - Cellular Functions and Gene and Protein Expression Profiles in Endothelial Cells Derived from Moyamoya Disease-Specific iPS Cells.
Hamauchi S; Shichinohe H; Uchino H; Yamaguchi S; Nakayama N; Kazumata K; Osanai T; Abumiya T; Houkin K; Era T
PloS one, 11, 9, e0163561, 2016, [Peer-reviewed]
English, Scientific journal - Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate-Supplementation for Cell Therapy against Stroke.
Tan C; Shichinohe H; Wang Z; Hamauchi S; Abumiya T; Nakayama N; Kazumata K; Ito T; Kudo K; Takamoto S; Houkin K
Stem cells international, 2016, 6104780, 6104780, 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal - Characteristics of Diffusional kurtosis in chronic ischemia of adult Moyamoya disease: Comparing Diffusional kurtosis and diffusion tensor imaging
Kazumata K; Tha K.K; Narita H; Ito Y.M; Shichinohe H; Ito M; Uchino H; Abumiya T
American Journal of Neuroradiology, 37, 8, 1432, 1439, 2016, [Peer-reviewed], [International Magazine]
English, Scientific journal - Inside Intramural Thrombus Formation with Inflammatory Reactions is Relevant to the Rupture of Cerebral Aneurysms
Shimoda Yusuke; Nakayama Naoki; Hokari Masaaki; Abumiya Takeo; Shichinohe Hideo; Kazumata Ken; Houkin Kiyohiro
JOURNAL OF NEUROSURGERY, 123, 2, A526, Aug. 2015, [Peer-reviewed] - Surgical Outcomes for Cervical Carotid Artery Stenosis: Treatment Strategy for Bilateral Cervical Carotid Artery Stenosis.
Hokari M; Nakayama N; Kazumata K; Osanai T; Nakamura T; Yasuda H; Ushikoshi S; Shichinohe H; Abumiya T; Kuroda S; Houkin K
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 24, 8, 1768, 1774, Aug. 2015, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: Carotid endarterectomy (CEA) and carotid stenting (CAS) are beneficial procedures for patients with high-grade cervical carotid stenosis. However, it is sometimes difficult to manage patients with bilateral carotid stenosis. To decide the treatment strategy, one of the most important questions is whether contralateral stenosis increases the risk of patients undergoing CEA. METHODS: This retrospective study included 201 patients with carotid stenosis who underwent a total of 219 consecutive procedures (CEA 189/CAS 30). We retrospectively analyzed outcomes in patients with carotid stenosis who were treated with either CEA or CAS and evaluated whether or not contralateral lesions increases the risk of patients undergoing CEA or CAS. Furthermore, we retrospectively verified our treatment strategy for bilateral carotid stenosis. RESULTS: The incidences of perioperative complications were 5.3% in the CEA patients and 6.7% in the CAS patients, respectively. There was no significant difference between these 2 groups. The existences of contralateral occlusion and/or contralateral stenosis were not associated with perioperative complications in both the groups. There were 32 patients with bilateral severe carotid stenosis (>50%). Of those, 13 patients underwent bilateral revascularizations; CEA followed by CEA in 8, CEA followed by CAS in 3, CAS followed by CEA + coronary artery bpass grafting in 1, and CAS followed by CAS in 1. CONCLUSIONS: Our date showed that the existence of contralateral carotid lesion was not associated with perioperative complications, and most of our cases with bilateral carotid stenosis initially underwent CEA. - Neuroprotective effects of cilostazol are mediated by multiple mechanisms in a mouse model of permanent focal ischemia.
Shichinohe H; Tan C; Abumiya T; Nakayama N; Kazumata K; Hokari M; Houkin K; Kuroda S
Brain research, 1602, 53, 61, Mar. 2015, [Peer-reviewed], [International Magazine]
English, Scientific journal, The phosphodiesterase (PDE) 3 inhibitor cilostazol, used as an anti-platelet drug, reportedly can also ameliorate ischemic brain injury. Here, we investigated the effects of cilostazol in a permanent focal ischemia mice model. Male Balb/c mice were subjected to permanent middle cerebral artery occlusion. Mice were then treated with either cilostazol (10 or 20mg/kg) or vehicle administered at 30min and 24h post-ischemia, and infarct volumes were assessed at 48h post-ischemia. Mice treated with 20mg/kg of cilostazol or vehicle were sacrificed at 6h or 24h post-ischemia and immunohistochemistry was used for brain sections. Treatment with 20mg/kg of cilostazol significantly reduced infarct volumes to 70.1% of those with vehicle treatment. Immunohistochemistry results for 8-hydroxydeoxyguanosine (OHdG) expression showed that some neurons underwent oxidative stress around the ischemic boundary zone at 6h post-ischemia. Cilostazol treatment significantly reduced the percentage of 8-OHdG-positive neurons (65.8±33.5% with vehicle and 21.3±9.9% with cilostazol). Moreover, NADPH oxidase (NOX) 2-positive neurons were significantly reduced with cilostazol treatment. In contrast, immunohistochemistry results for phosphorylated cyclic-AMP response element binding protein (pCREB) showed that there were significantly more pCREB-positive neurons around the ischemic boundary zone of cilostazol-treated mice than in those of vehicle-treated mice at 24h post-ischemia. These results suggested that cilostazol might have multiple mechanisms of action to ameliorate ischemic tissue damage, by attenuating oxidative stress mediated by suppressing NOX2 expression by ischemic neurons and an anti-apoptotic effect mediated through the pCREB pathway. - Cilostazol Can Attenuate Oxidative Stress by Suppressing Nox2 on Neurons in Mice Permanent Focal Ischemia
Shichinohe Hideo; Kuroda Satoshi; Tan Chengbo; Abumiya Takeo; Nakayama Naoki; Kazumata Ken; Hokari Masaaki; Houkin Kiyohiro
STROKE, 46, Feb. 2015, [Peer-reviewed] - Inside Intramural Thrombus Formation with Inflammatory Reactions Is Relevant to the Rupture of Cerebral Aneurysms
Shimoda Yusuke; Nakayama Naoki; Hokari Masaaki; Abumiya Takeo; Shichinohe Hideo; Kazumata Ken; Houkin Kiyohiro
STROKE, 46, Feb. 2015, [Peer-reviewed] - Post-ischemic Trans-arterial Regional Hypothermia Therapy Attenuates Microvascular Narrowing due to Astrocyte End-feet Swelling and Inhibits Subsequent Inflammatory Reactions in Ischemia Reperfusion Injury
Kurisu Kota; Abumiya Takeo; Nakamura Hideki; Shimbo Daisuke; Kazumata Ken; Nakayama Naoki; Shichinohe Hideo; Hokari Masaaki; Osanai Toshiya; Shimizu Hiroshi; Houkin Kiyohiro
STROKE, 46, Feb. 2015, [Peer-reviewed] - Utility of 4D-MRA to Measure Blood Flow Velocity in Cerebral Major Arteries
Abumiya Takeo; Fujima Noriyuki; Kudo Kohsuke; Ishi Yukitomo; Gekka Masayuki; Shichinohe Hideo; Kazumata Ken; Nakayama Naoki; Houkin Kiyohiro
STROKE, 46, Feb. 2015, [Peer-reviewed] - Chronic ischemia alters brain microstructural integrity and cognitive performance in adult moyamoya disease.
Kazumata K; Tha KK; Narita H; Kusumi I; Shichinohe H; Ito M; Nakayama N; Houkin K
Stroke, 46, 2, 354, 360, Feb. 2015, [Peer-reviewed], [International Magazine]
English, Scientific journal - Therapeutic Effects of Human Multilineage-Differentiating Stress Enduring (MUSE) Cell Transplantation into Infarct Brain of Mice.
Yamauchi T; Kuroda Y; Morita T; Shichinohe H; Houkin K; Dezawa M; Kuroda S
PloS one, 10, 3, e0116009, 3, 2015, [Peer-reviewed], [International Magazine]
English, Scientific journal, OBJECTIVE: Bone marrow stromal cells (BMSCs) are heterogeneous and their therapeutic effect is pleiotropic. Multilineage-differentiating stress enduring (Muse) cells are recently identified to comprise several percentages of BMSCs, being able to differentiate into triploblastic lineages including neuronal cells and act as tissue repair cells. This study was aimed to clarify how Muse and non-Muse cells in BMSCs contribute to functional recovery after ischemic stroke. METHODS: Human BMSCs were separated into stage specific embryonic antigen-3-positive Muse cells and -negative non-Muse cells. Immunodeficient mice were subjected to permanent middle cerebral artery occlusion and received transplantation of vehicle, Muse, non-Muse or BMSCs (2.5×104 cells) into the ipsilateral striatum 7 days later. RESULTS: Motor function recovery in BMSC and non-Muse groups became apparent at 21 days after transplantation, but reached the plateau thereafter. In Muse group, functional recovery was not observed for up to 28 days post-transplantation, but became apparent at 35 days post-transplantation. On immunohistochemistry, only Muse cells were integrated into peri-infarct cortex and differentiate into Tuj-1- and NeuN-expressing cells, while negligible number of BMSCs and non-Muse cells remained in the peri-infarct area at 42 days post-transplantation. CONCLUSIONS: These findings strongly suggest that Muse cells and non-Muse cells may contribute differently to tissue regeneration and functional recovery. Muse cells may be more responsible for replacement of the lost neurons through their integration into the peri-infarct cortex and spontaneous differentiation into neuronal marker-positive cells. Non-Muse cells do not remain in the host brain and may exhibit trophic effects rather than cell replacement. - Platelet lysate and granulocyte-colony stimulating factor serve safe and accelerated expansion of human bone marrow stromal cells for stroke therapy.
Yamauchi T; Saito H; Ito M; Shichinohe H; Houkin K; Kuroda S
Translational stroke research, 5, 6, 701, 710, Dec. 2014, [Peer-reviewed]
English, Scientific journal - 脳卒中再生医療 脳梗塞をターゲットとした自己骨髄間質細胞の定位移植治療
黒田 敏; 七戸 秀夫; 宝金 清博; 出澤 真理
脳循環代謝, 26, 1, 103, 103, (一社)日本脳循環代謝学会, Nov. 2014
Japanese - Short-, middle- and long-term safety of superparamagnetic iron oxide-labeled allogeneic bone marrow stromal cell transplantation in rat model of lacunar infarction.
Tan C; Shichinohe H; Abumiya T; Nakayama N; Kazumata K; Hokari M; Hamauchi S; Houkin K
Neuropathology : official journal of the Japanese Society of Neuropathology, 35, 3, 197, 208, Nov. 2014, [Peer-reviewed], [International Magazine]
English, Scientific journal, Recently, both basic and clinical studies demonstrated that bone marrow stromal cell (BMSC) transplantation therapy can promote functional recovery of patients with CNS disorders. A non-invasive method for cell tracking using MRI and superparamagnetic iron oxide (SPIO)-based labeling agents has been applied to elucidate the behavior of transplanted cells. However, the long-term safety of SPIO-labeled BMSCs still remains unclear. The aim of this study was to investigate the short-, middle- and long-term safety of the SPIO-labeled allogeneic BMSC transplantation. For this purpose, BMSCs were isolated from transgenic rats expressing green fluorescent protein (GFP) and were labeled with SPIO. The Na/K ATPase pump inhibitor ouabain or vehicle was stereotactically injected into the right striatum of wild-type rats to induce a lacunar lesion (n = 22). Seven days after the insult, either BMSCs or SPIO solution were stereotactically injected into the left striatum. A 7.0-Tesla MRI was performed to serially monitor the behavior of BMSCs in the host brain. The animals were sacrificed after 7 days (n = 7), 6 weeks (n = 6) or 10 months (n = 9) after the transplantation. MRI demonstrated that BMSCs migrated to the damage area through the corpus callosum. Histological analysis showed that activated microglia were present around the bolus of donor cells 7 days after the allogeneic cell transplantation, although an immunosuppressive drug was administered. The SPIO-labeled BMSCs resided and started to proliferate around the route of the cell transplantation. Within 6 weeks, large numbers of SPIO-labeled BMSCs reached the lacunar infarction area from the transplantation region through the corpus callosum. Some SPIO nanoparticles were phagocytized by microglia. After 10 months, the number of SPIO-positive cells was lower compared with the 7-day and 6-week groups. There was no tumorigenesis or severe injury observed in any of the animals. These findings suggest that BMSCs are safe after cell transplantation for the treatment of stroke. - Bone Marrow Stromal Cells Rescue Ischemic Brain by Trophic Effects and Phenotypic Change Toward Neural Cells.
Shichinohe H; Ishihara T; Takahashi K; Tanaka Y; Miyamoto M; Yamauchi T; Saito H; Takemoto H; Houkin K; Kuroda S
Neurorehabilitation and neural repair, 29, 1, 80, 9, Mar. 2014, [Peer-reviewed], [International Magazine]
English, Scientific journal, Background. Transplantation of bone marrow stromal cells (BMSCs) may contribute to functional recovery after stroke. This study was designed to clarify their mechanisms, trophic effects of neurotrophic factors, and neural differentiation. Methods. Mouse neurons exposed to glutamate were cocultured with mouse BMSCs. Either neutralizing antibodies against brain-derived neurotrophic factor (BDNF) or nerve growth factor (NGF) or Trk inhibitor K252a was added to explore the mechanism of their protective effects. Fluorescence in situ hybridization (FISH) was used to assess BDNF or NGF mRNA expression in BMSCs. The mice were subjected to permanent focal ischemia, and 7 days later, either BMSCs or the vehicle was stereotactically transplanted into the ipsilateral striatum. The mouse brains were processed for FISH and immunostaining 2 or 4 weeks after transplantation. Results. BMSCs significantly ameliorated glutamate-induced neuronal death. Treatment with anti-BDNF antibody significantly reduced their protective effects. FISH analysis showed that the majority of BMSCs expressed BDNF and NGF mRNA in vitro. BMSC transplantation significantly improved the survival of neurons in peri-infarct areas. FISH analysis revealed that approximately half of BMSCs expressed BDNF and NGF mRNA 2 weeks after transplantation; however, the percentage of BDNF and NGF mRNA-positive cells decreased thereafter. Instead, the percentage of microtubule-associated protein 2-positive BMSCs gradually increased during 4 weeks after transplantation. Conclusions. These findings strongly suggest that BDNF may be a key factor underlying the trophic effects of BMSCs. BMSCs might exhibit the trophic effect in the early stage of cell therapy and the phenotypic change toward neural cells thereafter. - Post-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin can reduce ischemia reperfusion injury.
Shimbo D; Abumiya T; Shichinohe H; Nakayama N; Kazumata K; Houkin K
Brain research, 1554, 59, 66, Elsevier, Mar. 2014, [Peer-reviewed]
English, Despite successful revascularization, reperfusion after prolonged ischemia causes ischemia reperfusion (I/R) injury. Recruitment and activation of neutrophils is thought to be a key event causing I/R injury. We examined whether post-ischemic intra-arterial infusion of liposome-encapsulated hemoglobin (LEH), an artificial oxygen carrier without neutrophils, could reduce I/R injury in a rat transient middle cerebral artery occlusion (MCAO) model. Male Sprague-Dawley rats were subjected to 2-h MCAO and then were divided into three groups: (1) LEH group (n=7) infused with LEH (Hb concentration of 6 g/dl, 10 ml/kg/h) through the recanalized internal carotid artery for 2 h, (2) vehicle group (n=8) infused with saline (10 ml/kg/h) in the same manner as the LEH group, and (3) control group (n=9) subjected to recanalization only. After 24-h reperfusion, all rats were tested for neurological score and then sacrificed to examine infarct and edema volumes, myeloperoxidase (MPO) expression, matrix metalloproteinase-9 (MMP-9) expression and activity, and reactive oxygen species (ROS) production. Compared with the control group and the vehicle group, the LEH group showed a significantly better neurological score and significantly smaller infarct and edema volumes. MPO expression, MMP-9 expression and activity, and ROS production in the LEH group were also significantly lower than those in the control and vehicle groups. The results in the present study suggest that post-ischemic intra-arterial infusion of LEH can reduce I/R injury through reducing the effect of MMP-9, most likely produced by neutrophils. This therapeutic strategy may be a promising candidate to prevent I/R injury after thrombolysis and/or thromboectomy. (C) 2014 Elsevier B.V. All rights reserved. - Spatial Relationship between Cerebral Microbleeds, Moyamoya Vessels, and Hematoma in Moyamoya Disease.
Kazumata K; Shinbo D; Ito M; Shichinohe H; Kuroda S; Nakayama N; Houkin K
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 23, 6, 1421, 8, Feb. 2014, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: Adult moyamoya disease (MMD) is known to have high incidence of cerebral microbleeds (cMBs); however, the clinical significance still remains unclear. We investigated the frequency of cMBs in a large number of patients and analyzed the patterns of MB distribution in association with the location of the hematoma and moyamoya vessels. METHODS: We studied 259 consecutive patients with MMD using prospectively collected database. One hundred ninety-one patients were eligible for the present study, and image analysis was performed retrospectively. The presence of cMBs and remains of hemorrhage were determined using gradient-echo T2*-weighted sequence (1.5 T). The development of moyamoya vessels was assessed on source images of time-of-flight magnetic resonance angiography. The analysis consists of descriptive assessment of the spatial relationship between cMB, remains of hemorrhage, and moyamoya vessels. Statistical analysis was performed to calculate relative risk ratio in the presence of cMBs in relation to the remains of hemorrhage (macrohematoma), age of onset, and the presence of concomitant moyamoya vessels. RESULTS: Thirty MBs were observed in 20 adult MMD patients (16.9%). MBs were located predominantly in the periventricular white matter (63.3%) followed by the basal ganglia/thalami (20%). Comparing the patients with cMBs from those without, hematoma was more frequently observed in patients with cMBs (odds ratio [OR] 4.29; 95% confidence interval [CI] 1.58-11.62; P=.0062). Patients with adult onset was more likely to demonstrate cMBs (14.4%) compared with the patients with pediatric onset (4.1%) (OR 3.93; 95% CI 1.11-13.91). Moyamoya vessels appeared in the lateral part of the trigon, and the periventricular white matter was significantly associated with the presence of cMBs (lateral part of the trigon; OR 3.29 [1.59-6.82], P=.0019, periventricle of the body of lateral ventricle; OR 2.40 [1.20-4.79], P=.0214, respectively). cMBs accompanied concomitant arteries in 23 (76.7%) lesions. The subependymal-leptomeningeal artery anastomosis was the most common pattern (n=20, 66.7%). CONCLUSIONS: Spatial relationship was demonstrated between the moyamoya vessels and perivascular hemosiderin deposition particularly around the subependymal-leptomeningeal anastomosis, suggesting the mechanism for the development of cMBs in MMD. Present study further supports previous findings that cMBs potentially serve as a marker for the bleeding-prone microangiopathy in MMD. The significance of the present study lies in selecting optimal surgical candidate for preventing future hemorrhage by the presence of the cMBs, whereas current surgical indication relying on the degree of ischemia frequently fails to detect patients with future hemorrhage. - Ivy sign, misery perfusion, and asymptomatic moyamoya disease: FLAIR imaging and (15)O-gas positron emission tomography.
Vuignier S; Ito M; Kurisu K; Kazumata K; Nakayama N; Shichinohe H; Shiga T; Kiss JZ; Tamaki N; Houkin K
Acta neurochirurgica, 155, 11, 2097, 2104, Nov. 2013, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: The prevalence of ivy sign on fluid-attenuated inversion recovery (FLAIR) imaging in patients with asymptomatic moyamoya disease is unclear. The aim of this study was to clarify the incidence of ivy sign in these patients, as well as the correlation between MRI and (15)O gas PET findings. METHODS: A retrospective analysis including 16 consecutive patients with asymptomatic moyamoya disease enrolled between 2001 and 2010 in a single center. FLAIR imaging at the initial visit was categorized as ivy sign present, negative, or equivocal. Hemodynamic and metabolic parameters were quantified in 11 of 16 patients by (15)O-gas positron emission tomography, and the relationship between ivy sign and (15)O-gas PET parameters was analyzed. Cerebrovascular events within the follow-up period (54 ± 28 months) were also examined. RESULTS: Five of 16 asymptomatic moyamoya patients (31.3 %) had positive ivy sign (6/30 hemispheres, 20 %). In (15)O-gas PET examinations, 18 % of 22 hemispheres had elevated oxygen extraction fraction values that were significantly associated with positive ivy sign. Of these 16 asymptomatic moyamoya patients, six patients (37.5 %) underwent combined surgical revascularization. In this series, no patients experienced ischemic stroke, but one had intraventricular bleeding 1 year after surgery. CONCLUSIONS: Ivy sign on FLAIR imaging is still not rare in patients with moyamoya disease, even when asymptomatic. Although optimal management is still under debate, ivy sign may be an indicator of misery perfusion, and patients with asymptomatic moyamoya disease and ivy sign on FLAIR imaging will benefit from more careful follow-up. - 123I-Iomazenil Single Photon Emission Computed Tomography Visualizes Recovery of Neuronal Integrity by Bone Marrow Stromal Cell Therapy in Rat Infarct Brain.
Saito H; Magota K; Zhao S; Kubo N; Kuge Y; Shichinohe H; Houkin K; Tamaki N; Kuroda S
Stroke, 44, 10, 2869, 2874, Oct. 2013, [Peer-reviewed], [International Magazine]
English, Research society, BACKGROUND AND PURPOSE: This study was aimed to assess whether (123)I-iomazenil (IMZ) single photon emission computed tomography can serially monitor the effects of bone marrow stromal cell (BMSC) transplantation on neuronal integrity in infarct brain of rats. METHODS: The BMSCs were harvested from green fluorescent protein-transgenic rats and were cultured. The rats were subjected to permanent middle cerebral artery occlusion. Their motor function was serially quantified throughout the experiments. The BMSCs or vehicle was stereotactically transplanted into the ipsilateral striatum at 7 days after the insult. Using small-animal single photon emission computed tomography/computed tomography apparatus, the (123)I-IMZ uptake was serially measured at 6 and 35 days after the insult. Finally, fluorescence immunohistochemistry was performed to evaluate the distribution of engrafted cells and their phenotypes. RESULTS: The distribution of (123)I-IMZ was markedly decreased in the ipsilateral neocortex at 6 days postischemia. The vehicle-transplanted animals did not show a significant change at 35 days postischemia. However, BMSC transplantation significantly improved the distribution of (123)I-IMZ in the peri-infarct neocortex as well as motor function. The engrafted BMSCs were densely distributed around cerebral infarct, and some of them expressed neuronal nuclear antigen and γ-aminobutyric acid type-A receptor. CONCLUSIONS: The present findings strongly suggest that the BMSCs may enhance functional recovery by improving the neuronal integrity in the peri-infarct area, when directly transplanted into the infarct brain at clinically relevant timing. (123)I-IMZ single photon emission computed tomography may be a promising modality to scientifically prove the beneficial effects of BMSC transplantation on the host brain in clinical situation. - Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct
Masahito Kawabori; Satoshi Kuroda; Masaki Ito; Hideo Shichinohe; Kiyohiro Houkin; Yuji Kuge; Nagara Tamaki
NEUROPATHOLOGY, 33, 2, 140, 148, Apr. 2013, [Peer-reviewed]
English, Scientific journal - 骨髄間質細胞移植によるラクナ梗塞モデルの中枢神経再生
七戸秀夫; 黒田敏; 宮本倫行; 山内朋裕; 斎藤久泰; 新保大輔; 数又研; 中山若樹; 寶金清博
再生医療, 12, 237, 28 Feb. 2013
Japanese - Post-ischemic Intra-arterial Infusion of Liposome-encapsulated Hemoglobin Can Reduce Ischemic Reperfusion Injury
Shimbo Daisuke; Abumiya Takeo; Shichinohe Hideo; Nakayama Naoki; Kazumata Ken; Houkin Kiyohiro; Ishizuka Takanobu
STROKE, 44, 2, Feb. 2013, [Peer-reviewed] - Impaired Cerebrovascular Reactivity to Acetazolamide in Parent Arterial Territory of Major Artery Aneurysms in Adult Patients with Moyamoya Disease
Ito Masaki; Houkin Kiyohiro; Niiya Yoshimasa; Uchino Haruto; Mabuchi Shoji; Nakayama Naoki; Kazumata Ken; Shichinohe Hideo; Sugiyama Taku; Ishii Nobuaki; Nomura Mikio
STROKE, 44, 2, Feb. 2013, [Peer-reviewed] - Bone marrow stromal cell transplantation enhances recovery of local glucose metabolism after cerebral infarction in rats: A serial 18F-FDG PET study
Michiyuki Miyamoto; Satoshi Kuroda; Songji Zhao; Keiichi Magota; Hideo Shichinohe; Kiyohiro Houkin; Yuji Kuge; Nagara Tamaki
Journal of Nuclear Medicine, 54, 1, 145, 150, Jan. 2013, [Peer-reviewed]
English, Scientific journal - Bone marrow stromal cell transplantation enhances recovery of motor function after lacunar stroke in rats.
Shichinohe H; Yamauchi T; Saito H; Houkin K; Kuroda S
Acta neurobiologiae experimentalis, 73, 3, 354, 363, 3, 2013, [Peer-reviewed], [International Magazine]
English, Scientific journal, This study was aimed to clarify if the bone marrow stromal cells (BMSCs) significantly improve functional outcome after lacunar stroke when stereotactically transplanted into the brain. Ouabain, a Na/K ATPase pump inhibitor, was stereotactically injected into the right striatum of Wistar rats. One week later, the superparamagnetic iron oxide (SPIO)-labeled rat BMSCs (n=7) or vehicle (n=8) were stereotactically transplanted into the left striatum. Using rotarod test, motor function was serially evaluated through the experiment. A 7.0-T MR apparatus was employed to serially monitor the migration of BMSCs in the host brain. Histological analysis was performed at 7 weeks after ouabain injection, i.e., 6 weeks after BMSC transplantation. Ouabain injection yielded the reproducible, focal lesion in the right striatum, causing continuous motor dysfunction throughout the experiment. BMSC transplantation significantly enhanced the recovery of motor function after ouabain injection. MR imaging demonstrated that the BMSCs aggressively migrated towards the lesion through the corpus callosum. Histological analysis supported the findings on MRI. The BMSCs significantly enhanced the neurogenesis in the subventricular zone (SVZ) on both sides. Some of them also expressed neuronal or astrocytic phenotypes in the neocortex, SVZ, corpus callosum, and peri-lesion area. These findings strongly suggest that the BMSCs may serve therapeutic impacts on lacunar stroke when stereotactically transplanted at clinically relevant timing. - 骨髄間質細胞の動脈内送達の治療効果(Therapeutic effects of intra-arterial delivery of bone marrow stromal cells)
長内 俊也; 黒田 敏; 七戸 秀夫; 久下 裕司; 玉木 長良; 宝金 清博
脳循環代謝, 24, 1, 147, 147, (一社)日本脳循環代謝学会, Nov. 2012
Japanese - Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: An optical imaging study
Masahito Kawabori; Satoshi Kuroda; Taku Sugiyama; Masaki Ito; Hideo Shichinohe; Kiyohiro Houkin; Yuji Kuge; Nagara Tamaki
NEUROPATHOLOGY, 32, 3, 217, 226, Jun. 2012, [Peer-reviewed]
English, Scientific journal - Review of Past Research and Current Concepts on the Etiology of Moyamoya Disease
Kiyohiro Houkin; Masaki Ito; Taku Sugiyama; Hideo Shichinohe; Naoki Nakayama; Ken Kazumata; Satoshi Kuroda
NEUROLOGIA MEDICO-CHIRURGICA, 52, 5, 267, 277, May 2012, [Peer-reviewed]
English - Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: functional enhancement by granulocyte-colony stimulating factor (G-CSF).
Yasuhiro Chiba; Satoshi Kuroda; Toshiya Osanai; Hideo Shichinohe; Kiyohiro Houkin; Yoshinobu Iwasaki
Neuropathology : official journal of the Japanese Society of Neuropathology, 32, 2, 139, 48, 2, Apr. 2012, [Peer-reviewed], [International Magazine]
English, Scientific journal, This study was designed to clarify the effects of donor age on biological features of bone marrow stromal cells (BMSC), one of the candidates for cell transplantation therapy for CNS disorders, because many aged patients might require such therapy. This study was also aimed to test whether ex vivo treatments with granulocyte-colony stimulating factor (G-CSF) could modify biological properties of BMSC from aged donors and enhance its therapeutic effects in an animal model of traumatic brain injury. The BMSC were harvested from young (6-week-old) and aged (100-week-old) rats. The ageing significantly increased the senescence-associated β-galactosidase (SA-β-gal) activity of the cultured BMSC, and decreased their proliferative capacity and production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). As the next step, the rats were subjected to brain freezing injury by applying liquid nitrogen onto the neocortex through the thinned skull. The 6-week BMSC, 100-week BMSC, G-CSF-treated 100-week BMSC or vehicle were stereotactically injected into the ipsilateral striatum at 7 days post-injury. Transplantation of the 6-week BMSC, but not 100-week BMSC, significantly improved locomotor function. However, treatment of the 100-week BMSC with 0.1 µmol of G-CSF significantly improved their proliferation activity and growth factor production, and recovered therapeutic effects in the injured brain. In conclusion, donor age may largely determine biological aspects of BMSC. G-CSF may contribute to improve the outcome of BMSC transplantation therapy for CNS disorders in aged patients. - Visualization of the Superparamagnetic Iron Oxide (SPIO)-Labeled Bone Marrow Stromal Cells Using a 3.0-T MRI-a Pilot Study for Clinical Testing of Neurotransplantation.
Shichinohe H; Kuroda S; Kudo K; Ito M; Kawabori M; Miyamoto M; Nakanishi M; Terae S; Houkin K
Translational stroke research, 3, 1, 99, 106, Mar. 2012, [Peer-reviewed], [International Magazine]
English, Scientific journal - Therapeutic effects of intra-arterial delivery of bone marrow stromal cells in traumatic brain injury of rats--in vivo cell tracking study by near-infrared fluorescence imaging.
Toshiya Osanai; Satoshi Kuroda; Taku Sugiyama; Masahito Kawabori; Masaki Ito; Hideo Shichinohe; Yuji Kuge; Kiyohiro Houkin; Nagara Tamaki; Yoshinobu Iwasaki
Neurosurgery, 70, 2, 435, 44, 2, Feb. 2012, [Peer-reviewed], [International Magazine]
English, Scientific journal, BACKGROUND: A noninvasive and effective route of cell delivery should be established to yield maximal therapeutic effects for central nervous system (CNS) disorders. OBJECTIVE: To elucidate whether intra-arterial delivery of bone marrow stromal cells (BMSCs) significantly promotes functional recovery in traumatic brain injury (TBI) in rats. METHODS: Rat BMSCs were transplanted through the ipsilateral internal carotid artery 7 days after the onset of cortical freezing injury. The BMSCs were labeled with fluorescent dye, and in vivo optical imaging was employed to monitor the behaviors of cells for 4 weeks after transplantation. Motor function was assessed for 4 weeks, and the transplanted BMSCs were examined using immunohistochemistry. RESULTS: In vivo optical imaging and histologic analysis clearly demonstrated that the intra-arterially injected BMSCs were engrafted during the first pass without systemic circulation, and the transplanted BMSCs started to migrate from the cerebral capillary bed to the injured CNS tissue within 3 hours. Intra-arterial BMSC transplantation significantly promoted functional recovery after cortical freezing injury. A subgroup of BMSCs expressed the phenotypes of neurons, astrocytes, and endothelial cells around the injured neocortex 4 weeks after transplantation. CONCLUSION: Intra-arterial transplantation may be a valuable option for prompt, noninvasive delivery of BMSCs to the injured CNS tissue, enhancing functional recovery after TBI. In vivo optical imaging may provide important information on the intracerebral behaviors of donor cells by noninvasive, serial visualization. - Topography of Hemorrhage and Microbleeds in Adult Moyamoya Disease
Kazumata Ken; Houkin Kiyohiro; Nakayama Naoki; Shichinohe Hideo; Osanai Toshiya; Shinpo Daisuke; Saito Hisayasu
CEREBROVASCULAR DISEASES, 34, 32, 2012, [Peer-reviewed] - Irregular Neointimal Lining with Prominent Proliferative Activity in a Patient Underwent Patch Angioplasty for Carotid Endarterectomy - An Autopsy Case Report
Ito Masaki; Niiya Yoshimasa; Uchino Haruto; Itosaka Hiroyuki; Shichinohe Hideo; Kazumata Ken; Nakayama Naoki; Mabuchi Syoji; Houkin Kiyohiro
CEREBROVASCULAR DISEASES, 34, 102, 2012, [Peer-reviewed] - 人工酸素運搬体Liposome‐encapsulated hemoglobinを用いた虚血再灌流傷害の治療戦略
新保大輔; 鐙谷武雄; 七戸秀夫; 中山若樹; 数又研; 宝金清博; 石塚隆伸
脳循環代謝, 24, 1, 178, 178, (一社)日本脳循環代謝学会, 2012
Japanese - 骨髄間質細胞移植は脳梗塞周囲の神経受容体機能を改善させる―123I‐iomazenil SPECTによる検討
齋藤久泰; 黒田敏; 宮本倫行; 山内朋裕; 七戸秀夫; 趙松吉; 孫田惠一; 久保直樹; 久下裕司; 玉木長良; 寶金清博
脳循環代謝, 24, 1, 216, 2012
English, Research society - 骨髄間質細胞移植は脳梗塞後の局所糖代謝を改善する―小動物用PET/CTによる検討
宮本倫行; 黒田敏; 趙松吉; 孫田恵一; 伊東雅基; 川堀真人; 丸一勝彦; 七戸秀夫; 宝金清博; 久下裕司; 玉木長良
再生医療, 11, 191, 2012
Japanese, Research society - 脳梗塞をターゲットとした骨髄間質細胞移植―新たな培養・移植・イメージング技術による展開
黒田敏; 宮本倫行; 山内朋裕; 斉藤久泰; 伊東雅基; 川堀真人; 杉山拓; 千葉泰弘; 七戸秀夫; 宝金清博; 久下裕司; 趙松吉; 玉木長良
再生医療, 11, 136, 2012
Japanese, Research society - Validity of bone marrow stromal cell expansion by animal serum-free medium for cell transplantation therapy of cerebral infarct in rats-a serial MRI study.
Ito M; Kuroda S; Sugiyama T; Shichinohe H; Takeda Y; Nishio M; Koike T; Houkin K
Translational stroke research, 2, 3, 294, 306, Sep. 2011, [Peer-reviewed], [International Magazine]
English, Scientific journal, This study was aimed to test the hypothesis that human bone marrow stromal cells (hBMSC) expanded in fetal calf serum (FCS)-free, platelet lysate (PL)-containing medium would retain their capacity of migration, survival, and neural differentiation when transplanted into the infarct brain, using serial in vivo magnetic resonance imaging (MRI). Cell growth kinetic analysis revealed that hBMSC maintain their proliferative activity when cultured either in conventional FCS-containing medium or FCS-free, PL-containing medium. Subsequently, hBMSC were labeled with a superparamagnetic iron oxide agent and were stereotactically transplanted into the ipsilateral striatum of rats at 7 days after permanent middle cerebral artery occlusion. Serial MRI performed over 8 weeks revealed that they retain their migratory capacity towards the cerebral infarct. Moreover, double fluorescence immunohistochemistry also revealed that they preserve their capacity of differentiation into the neural cells in the peri-infarct area. The hBMSC expanded in the FCS-free, PL-containing medium retain their capacity of migration, survival, and differentiation when stereotactically transplanted into the infarct brain. The present findings strongly suggest the clinical utility of PL as a substitute to expand autologous hBMSC for cerebral infarct in the future. - Biological Features of Human Bone Marrow Stromal Cells (hBMSC) Cultured with Animal Protein-Free Medium-Safety and Efficacy of Clinical Use for Neurotransplantation.
Shichinohe H; Kuroda S; Sugiyama T; Ito M; Kawabori M; Nishio M; Takeda Y; Koike T; Houkin K
Translational stroke research, 2, 3, 307, 315, Sep. 2011, [Peer-reviewed], [International Magazine]
English, Scientific journal, The donor cell culture in animal serum-free medium is quite important for the clinical application of cell transplantation therapy. This study was aimed to test the hypothesis that the human bone marrow stromal cells (hBMSC) expanded with fetal calf serum (FCS)-free, platelet lysate (PL)-containing medium retain their biological features favoring central nervous system regeneration. The hBMSC were cultured with 5% PL or 10% FCS. Their phenotypes were analyzed with flow cytometry, and their production of growth factors was quantified with enzyme-linked immunosorbent assay. Their capacity of neural differentiation was verified by immunocytochemistry. There was no significant difference in morphology and cell surface marker between the hBMSC-FCS and hBMSC-PL. Both of them were positive for CD44, CD90, CD105, and CD166 and were negative for CD34, CD45, and CD271. The production of human brain-derived neurotrophic factor, human hepatocyte growth factor, human β-nerve growth factor, and human platelet-derived growth factor-BB did not differ between the two groups, although the hBMSC-PL produced significantly more amount of TGF-β1 than the hBMSC-FCS. There was no significant difference in their in vitro differentiation into the neurons and astrocytes between the two groups. The hBMSC expanded with PL-containing medium retain their biological capacity of neural differentiation and neuroprotection. The PL may be a clinically valuable and safe substitute for FCS in expanding the hBMSC for cell therapy. - Therapeutic Impact of Human Bone Marrow Stromal Cells Expanded by Animal Serum-Free Medium for Cerebral Infarct in Rats
Taku Sugiyama; Satoshi Kuroda; Yukari Takeda; Mitsufumi Nishio; Masaki Ito; Hideo Shichinohe; Takao Koike
NEUROSURGERY, 68, 6, 1733, 1742, Jun. 2011, [Peer-reviewed]
English, Scientific journal - Near-Infrared Fluorescence Labeling Allows Noninvasive Tracking of Bone Marrow Stromal Cells Transplanted Into Rat Infarct Brain
Taku Sugiyama; Satoshi Kuroda; Toshiya Osanai; Hideo Shichinohe; Yuji Kuge; Masaki Ito; Masahito Kawabori; Yoshinobu Iwasaki
NEUROSURGERY, 68, 4, 1036, 1047, Apr. 2011, [Peer-reviewed]
English, Scientific journal - 骨髄間質細胞移植は脳梗塞後の局所糖代謝を改善する―小動物用PET/CTによる検討
宮本倫行; 黒田敏; 七戸秀夫; 伊東雅基; 川堀真人; 趙松吉; 孫田恵一; 久下裕司; 玉木長良; 宝金清博
脳循環代謝, 23, 1, 142, 142, (一社)日本脳循環代謝学会, 2011
English, Research society - Synergistic effects of bone marrow stromal cells and a Rho kinase (ROCK) inhibitor, fasudil on axon regeneration in rat spinal cord injury.
Yasuhiro Chiba; Satoshi Kuroda; Hideo Shichinohe; Masaaki Hokari; Toshiya Osanai; Katsuhiko Maruichi; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki
Neuropathology : official journal of the Japanese Society of Neuropathology, 30, 3, 241, 50, 3, Jun. 2010, [Peer-reviewed], [International Magazine]
English, Transplanted bone marrow stromal cells (BMSC) promote functional recovery after spinal cord injury (SCI) through multiple mechanisms. A Rho kinase inhibitor, Fasudil also enhances axonal regeneration. This study was aimed to evaluate whether combination therapy of BMSC transplantation and Fasudil further enhances axonal regeneration and functional recovery in rats subjected to SCI. Fasudil or vehicle was injected for 2 weeks. BMSC or vehicle transplantation into the rostral site of SCI was performed at 7 days after injury. Neurological symptoms were assessed throughout the experiments. Fluoro-Ruby was injected into the dorsal funiculus of the rostral site of SCI at 63 days after injury. The fate of the transplanted BMSC was examined using immunohistochemistry. BMSC transplantation significantly increased the number of Fluoro-Ruby -labeled fibers of the dorsal corticospinal tracts at the caudal site of SCI, enhancing functional recovery of the hind limbs. Some of the engrafted BMSC were positive for Fluoro-Ruby, neuronal specific nuclear protein and microtubule-associated protein-2, suggesting that they acquired neuronal phenotypes and built synaptic connection with the host's neural circuits. Fasudil treatment also improved axonal continuity, but did not promote functional recovery. Combination therapy dramatically increased the number of Fluoro-Ruby-labeled fibers of the dorsal corticospinal tracts at the caudal site of SCI, but did not further boost the therapeutic effects on locomotor function by BMSC transplantation. The findings suggest that BMSC transplantation and Fasudil provide synergistic effects on axon regeneration after SCI, although further studies would be necessary to further enhance functional recovery. - Noninvasive transplantation of bone marrow stromal cells for ischemic stroke: preliminary study with a thermoreversible gelation polymer hydrogel.
Toshiya Osanai; Satoshi Kuroda; Hiroshi Yasuda; Yasuhiro Chiba; Katsuhiko Maruichi; Masaaki Hokari; Taku Sugiyama; Hideo Shichinohe; Yoshinobu Iwasaki
Neurosurgery, 66, 6, 1140, 7, 6, Jun. 2010, [Peer-reviewed], [International Magazine]
English, OBJECTIVE: Recent studies have indicated that bone marrow stromal cells (BMSCs) have the potential to improve neurological function when transplanted into animal models of cerebral infarct. However, it is still undetermined how the BMSCs should be transplanted to obtain the most efficient therapeutic benefits safely. The aim of this study was to assess whether a thermoreversible gelation polymer (TGP) hydrogel acts as a noninvasive, valuable scaffold in BMSC transplantation for infarct brain. METHODS: The mice were subjected to permanent middle cerebral artery occlusion. Vehicle, BMSC suspension, or the BMSC-TGP construct was transplanted onto the ipsilateral intact neocortex at 7 days after the insult. Neurological symptoms were assessed throughout the experiments. The fate of the transplanted BMSC was examined 8 weeks after transplantation with immunohistochemistry. RESULTS: TGP hydrogel completely disappeared and provoked no inflammation in the host brain. Many transplanted cells were widely engrafted in the ipsilateral cerebrum, including the dorsal neocortex adjacent to the cerebral infarct in the BMSC-TGP construct-treated mice. Their number was significantly larger than in the BMSC-treated mice. The majority were positive for both NeuN and MAP2 and morphologically simulated the neurons. CONCLUSION: The findings suggest that surgical transplantation of tissue-engineered BMSCs onto the intact neocortex enhances the engraftment of donor cells around the cerebral infarct. These data may be useful in developing a noninvasive but efficient paradigm in neural tissue engineering. TGP hydrogel can be a promising candidate for valuable scaffolds in BMSC transplantation for central nervous system disorders because of its unique biochemical properties. - 中枢神経再生におけるバイオイメージング
杉山 拓; 伊東 雅基; 七戸 秀夫; 黒田 敏
再生医療, 9, 2, 257, 263, (株)メディカルレビュー社, May 2010, [Peer-reviewed]
Japanese - Bone marrow stromal cells and bone marrow-derived mononuclear cells: which are suitable as cell source of transplantation for mice infarct brain?
Hideo Shichinohe; Satoshi Kuroda; Katsuhiko Maruichi; Toshiya Osanai; Taku Sugiyama; Yasuhiro Chiba; Ayumi Yamaguchi; Yoshinobu Iwasaki
Neuropathology : official journal of the Japanese Society of Neuropathology, 30, 2, 113, 22, 2, Apr. 2010, [Peer-reviewed], [International Magazine]
English, There are few studies that denote whether bone marrow stromal cells (BMSC) and bone marrow-derived mononuclear cells (MNC) show the same therapeutic effects, when directly transplanted into the infarct brain. This study therefore aimed to compare their biological properties and behaviors in the infarct brain. Mouse BMSC were harvested and cultured. Mouse MNC were obtained through centrifugation techniques. Their cell markers were analyzed with FACS analysis. The MNC (10(6) cells; n = 10) or BMSC (2 x 10(5) cells; n = 10) were stereotactically transplanted into the ipsilateral striatum of the mice subjected to permanent middle cerebral artery occlusion at 7 days after the insult. Their survival, migration, and differentiation in the infarct brain were precisely analyzed using immunohistochemistry 4 weeks after transplantation. The MNC were positive for CD34, CD45, CD90, but were negative for Sca-1. The BMSC were positive for CD90 and Sca-1. The transplanted BMSC, but not MNC, extensively migrated into the peri-infarct area. Approximately 20% of the transplanted BMSC expressed a neuronal marker, NeuN in the infarct brain, although only 1.4% of the transplanted MNC expressed NeuN. These findings strongly suggest that there are large, biological differences between MNC and BMSC as cell sources of regenerative medicine for ischemic stroke. - Effect of biodegradable fibrin scaffold on survival, migration, and differentiation of transplanted bone marrow stromal cells after cortical injury in rats Laboratory investigation
Hiroshi Yasuda; Satoshi Kuroda; Hideo Shichinohe; Shintaro Kamei; Ryoichi Kawamura; Yoshinobu Iwasaki
JOURNAL OF NEUROSURGERY, 112, 2, 336, 344, Feb. 2010, [Peer-reviewed]
English, Scientific journal - Thermoreversible Gelation Polymer (TGP) Hydrogel as a Degradable Scaffold for Bone Marrow Stromal Cell Transplantation
Toshiya Osanai; Satoshi Kuroda; Hiroshi Yasuda; Yasuhiro Chiba; Katsuhiko Maruichi; Masaaki Hokari; Taku Sugiyama; Hideo Shichinohe; Yoshinobu Iwasaki
Molecular Imaging for Integrated Medical Therapy and Drug Development, 145, 151, Springer Japan, 2010
In book - Noninvasive Optical Tracking of Bone Marrow Stromal Cells Transplanted into Rat Cerebral Infarct
Taku Sugiyama; Satoshi Kuroda; Toshiya Osanai; Katsuhiko Maruichi; Yasuhiro Chiba; Hideo Shichinohe; Yuji Kuge; Nagara Tamaki; Yoshinobu Iwasaki
Molecular Imaging for Integrated Medical Therapy and Drug Development, 139, 144, Springer Japan, 2010
In book - Bone Marrow Stromal Cell Transplantation Attenuates Cognitive Dysfunction due to Chronic Cerebral Ischemia in Rats
Hideo Shichinohe; Satoshi Kuroda; Taku Sugiyama; Masaki Ito; Masahito Kawabori
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 30, 4, 293, 301, 2010, [Peer-reviewed]
English, Scientific journal - Transplanted bone marrow stromal cells improves cognitive dysfunction due to diffuse axonal injury in rats
Katsuhiko Maruichi; Satoshi Kuroda; Yasuhiro Chiba; Masaaki Hokari; Hideo Shichinohe; Kazutoshi Hida; Yoshinobu Iwasaki
NEUROPATHOLOGY, 29, 4, 422, 432, Aug. 2009, [Peer-reviewed]
English, Scientific journal - Fibrin matrix provides a suitable scaffold for bone marrow stromal cells transplanted into injured spinal cord: A novel material for CNS tissue engineering
Hiroyuki Itosaka; Satoshi Kuroda; Hideo Shichinohe; Hiroshi Yasuda; Shunsuke Yano; Shintaro Kamei; Ryoichi Kawamura; Kazutoshi Hida; Yoshinobu Iwasaki
NEUROPATHOLOGY, 29, 3, 248, 257, Jun. 2009, [Peer-reviewed]
English, Scientific journal - Transplanted bone marrow stromal cells promote axonal regeneration and improve motor function in a rat spinal cord injury model.
Yasuhiro Chiba; Satoshi Kuroda; Katsuhiko Maruichi; Toshiya Osanai; Masaaki Hokari; Shunsuke Yano; Hideo Shichinohe; Kazutoshi Hida; Yoshinobu Iwasaki
Neurosurgery, 64, 5, 991, 9, 5, May 2009, [Peer-reviewed], [International Magazine]
English, OBJECTIVE: Recent studies have indicated that bone marrow stromal cells (BMSCs) have the potential to improve neurological function when transplanted into animal models of spinal cord injury (SCI). However, it is still unclear how the transplanted BMSCs promote functional recovery after SCI. In this study, therefore, we evaluated how the transplanted BMSCs restore the function of the dorsal corticospinal tracts in the injured spinal cord. METHODS: The rats were subjected to incomplete SCI by means of a pneumatic impact device. BMSC or vehicle transplantation into the rostral site of SCI was performed at 7 days after injury. Neurological symptoms were assessed throughout the experiments. Fluoro-Ruby was injected into the dorsal funiculus of the rostral site of SCI at 63 days after injury. The fate of the transplanted BMSCs was examined using immunohistochemistry. RESULTS: BMSC transplantation significantly enhanced functional recovery of the hind limbs. The number of Fluoro-Ruby-labeled fibers of the dorsal corticospinal tracts at the caudal site of SCI was significantly higher in the BMSC-transplanted animals than in the vehicle-transplanted animals. Some of the engrafted BMSCs were positive for Fluoro-Ruby, NeuN, and MAP2 in the gray matter, suggesting that they acquired neuronal phenotypes and built synaptic connection with the host's neural circuits. Others in the white matter morphologically simulated the astrocytes and were also positive for glial fibrillary acidic protein. CONCLUSION: The findings suggest that the transplanted BMSCs acquire neural cell phenotypes around the injury site and contribute to rebuild the neural circuits, including the corticospinal tract, promoting functional recovery of the hind limbs. - Graded model of diffuse axonal injury for studying head injury-induced cognitive dysfunction in rats
Katsuhiko Maruichi; Satoshi Kuroda; Yasuhiro Chiba; Masaaki Hokari; Hideo Shichinohe; Kazutoshi Hida; Yoshinobu Iwasaki
NEUROPATHOLOGY, 29, 2, 132, 139, Apr. 2009, [Peer-reviewed]
English, Scientific journal - Edaravone (MCI-186) Scavenges Reactive Oxygen Species and Ameliorates Tissue Damage in the Murine Spinal Cord Injury Model
Takeshi Aoyama; Kazutoshi Hida; Satoshi Kuroda; Toshitaka Seki; Shunsuke Yano; Hideo Shichinohe; Yoshinobu Iwasaki
NEUROLOGIA MEDICO-CHIRURGICA, 48, 12, 539, 545, Dec. 2008, [Peer-reviewed]
English, Scientific journal - Bone marrow stromal cells promote neurite extension in organotypic spinal cord slice: Significance for cell transplantation therapy
Hideo Shichinohe; Satoshi Kuroda; Sachiko Tsuji; Satoshi Yamaguchi; Shunsuke Yano; Jang-Bo Lee; Hiroyuki Kobayashi; Seiji Kikuchi; Kazutoshi Hida; Yoshinobu Iwasaki
NEUROREHABILITATION AND NEURAL REPAIR, 22, 5, 447, 457, Sep. 2008, [Peer-reviewed]
English, Scientific journal - Mouse model of focal cerebral ischemia using endothelin-1
Nobutaka Horie; Arme-Lise Maag; Scott A. Hamilton; Hideo Shichinohe; Tonya M. Bliss; Gary K. Steinberg
JOURNAL OF NEUROSCIENCE METHODS, 173, 2, 286, 290, Aug. 2008, [Peer-reviewed]
English, Scientific journal - An siRNA against JC virus (JCV) agnoprotein inhibits JCV infection in JCV-producing cells inoculated in nude mice
Tomoko Matoba; Yasuko Orba; Tadaki Suzuki; Yoshinori Makino; Hideo Shichinohe; Satoshi Kuroda; Takahiro Ochiya; Hiroshi Itoh; Shinya Tanaka; Kazuo Nagashima; Hirofumi Sawa
NEUROPATHOLOGY, 28, 3, 286, 294, Jun. 2008, [Peer-reviewed]
English, Scientific journal - Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms
Masaaki Hokari; Satoshi Kuroda; Hideo Shichinohe; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki
JOURNAL OF NEUROSCIENCE RESEARCH, 86, 5, 1024, 1035, Apr. 2008, [Peer-reviewed]
English, Scientific journal - Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct
Hideo Shichinohe; Satoshi Kuroda; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki
BRAIN RESEARCH, 1183, 138, 147, Dec. 2007, [Peer-reviewed]
English, Scientific journal - Bone marrow stromal cell transplantation preserves gammaaminobutyric acid receptor function in the injured spinal cord
Shunsuke Yano; Satoshi Kuroda; Hideo Shichinohe; Toshitaka Seki; Takako Ohnishi; Hiroshi Tamagami; Kazutoshi Hida; Yoshinobu Iwasaki
JOURNAL OF NEUROTRAUMA, 23, 11, 1682, 1692, Nov. 2006, [Peer-reviewed]
English, Scientific journal - Susceptibility of brain microvascular endothelial cells to advanced glycation end products-induced tissue factor upregulation is associated with intracellular reactive oxygen species
Yoshimasa Niiya; Takeo Abumiya; Hideo Shichinohe; Satoshi Kuroda; Seiji Kikuchi; Masahiro Ieko; Sho-ichi Yamagishi; Masayoshi Takeuchi; Takashi Sato; Yoshinobu Iwasaki
BRAIN RESEARCH, 1108, 179, 187, Sep. 2006, [Peer-reviewed]
English, Scientific journal - The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC) - a preliminary study using microarray analysis
S Yamaguchi; S Kuroda; H Kobayashi; H Shichinohe; S Yano; K Hida; K Shinpo; S Kikuchi; Y Iwasaki
BRAIN RESEARCH, 1087, 15, 27, May 2006, [Peer-reviewed]
English, Scientific journal - Improved expression of gamma-aminobutyric acid receptor in mice with cerebral infarct and transplanted bone marrow stromal cells: An autoradiographic and histologic analysis
Hideo Shichinohe; Satoshi Kuroda; Shunsuke Yano; Takako Ohnishi; Hiroshi Tamagami; Kazutoshi Hida; Yoshinobu Iwasaki
JOURNAL OF NUCLEAR MEDICINE, 47, 3, 486, 491, Mar. 2006, [Peer-reviewed]
English, Scientific journal - Do bone marrow stromal cells proliferate after transplantation into mice cerebral infarct? A double labeling study
S Yano; S Kuroda; H Shichinohe; K Hida; Y Iwasaki
BRAIN RESEARCH, 1065, 1-2, 60, 67, Dec. 2005, [Peer-reviewed]
English, Scientific journal - In vivo fluorescence tracking of bone marrow stromal cells transplanted into a pneumatic injury model of rat spinal cord
S Yano; S Kuroda; JB Lee; H Shichinohe; T Seki; J Ikeda; G Nishimura; K Hida; M Tamura; Y Iwasaki
JOURNAL OF NEUROTRAUMA, 22, 8, 907, 918, Aug. 2005, [Peer-reviewed]
English, Scientific journal - Novel stent/CEA strategy for patients with bilateral carotid artery stenosis and coronary artery disease: Report of 2 cases
H Shichinohe; S Kuroda; T Asano; S Ushikoshi; T Ishikawa; K Houkin; T Murashita; Y Iwasaki
NEUROLOGICAL SURGERY, 33, 2, 149, 153, Feb. 2005, [Peer-reviewed]
Japanese, Scientific journal - 冠動脈病変を合併した両側内頸動脈狭窄症に対するstent/CEA複合治療の経験
七戸 秀夫; 黒田 敏; 浅野 剛; 牛越 聡; 石川 達哉; 宝金 清博; 村下 十志文; 岩崎 喜信
Neurological Surgery, 33, 2, 149, 153, (株)医学書院, Feb. 2005
Japanese, 症例1:49歳男.構音障害と右不全麻痺で発症し,両側内頸動脈に90%狭窄を認めると共に,慢性心不全,冠動脈三枝疾患の合併が判明した.冠動脈バイパス術(CABG)単独では両側大脳半球の灌流圧が著明に低下する危険が高いと考え,まず無症候性の右内頸動脈起始部の狭窄病変に対してstentを用いた血管形成術を施行した.翌日に左頸動脈内膜剥離術(CEA)および冠動脈バイパス術(CABG)を同時に行った.術後頸動脈の狭窄は改善し,両側性に脳血流量の増加を認め,5年経過し再発はない.症例2:62歳男.2年前,労作性狭心症でstentを併用した血管形成術を施行された.しかし,冠動脈狭窄が再発してCABGの適応となり,術前スクリーニングで両側の頸部内頸動脈に狭窄を指摘された.早期にCABGを実施する必要から,まず狭窄が比較的穏やかな右内頸動脈起始部の狭窄病変に対してSMART stentを留置し,1週間後に左CEAを施行した.その3週間後にCABGを施行し,周術期合併症はなかった - Carotid occlusive disease presenting with loss of consciousness
D Kashiwazaki; S Kuroda; S Terasaka; T Ishikawa; H Shichinohe; T Aoyama; S Ushikoshi; M Nunomura; Y Iwasaki
NEUROLOGICAL SURGERY, 33, 1, 29, 34, Jan. 2005, [Peer-reviewed]
Japanese, Scientific journal - Neuroprotective effect of a heat shock protein inducer, geranylgeranylacetone in permanent focal cerebral ischemia
H Yasuda; H Shichinohe; S Kuroda; T Ishikawa; Y Iwasaki
BRAIN RESEARCH, 1032, 1-2, 176, 182, Jan. 2005, [Peer-reviewed]
English, Scientific journal - Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia
H Shichinohe; S Kuroda; H Yasuda; T Ishikawa; M Iwai; M Horiuchi; Y Iwasaki
BRAIN RESEARCH, 1029, 2, 200, 206, Dec. 2004, [Peer-reviewed]
English, Scientific journal - A pre-clinical assessment model of rat autogeneic bone marrow stromal cell transplantation into the central nervous system
JB Lee; S Kuroda; H Shichinohe; S Yano; H Kobayashi; K Hida; Y Iwasaki
BRAIN RESEARCH PROTOCOLS, 14, 1, 37, 44, Nov. 2004, [Peer-reviewed]
English, Scientific journal - In vivo tracking of bone marrow stromal cells transplanted into mice cerebral infarct by fluorescence optical imaging
H Shichinohe; S Kuroda; JB Lee; G Nishimura; S Yano; T Seki; J Ikeda; M Tamura; Y Iwasaki
BRAIN RESEARCH PROTOCOLS, 13, 3, 166, 175, Aug. 2004, [Peer-reviewed]
English, Scientific journal - FK506 reduces infarct volume due to permanent focal cerebral ischemia by maintaining BAD turnover and inhibiting cytochrome c release
H Shichinohe; S Kuroda; T Abumiya; J Ikeda; T Kobayashi; T Yoshimoto; Y Iwasaki
BRAIN RESEARCH, 1001, 1-2, 51, 59, Mar. 2004, [Peer-reviewed]
English, Scientific journal - 脳ミトコンドリアは虚血においてどのような挙動を示すのか?
黒田 敏; 七戸 秀夫; 小林 徹; 吉本 哲之; 鐙谷 武雄; 石川 達哉; 多田 光宏; 中井 章人; 宝金 清博; 岩崎 喜信
Pharma Medica, 22, 2, 130, 130, (株)メディカルレビュー社, Feb. 2004
Japanese - A case of jugular phlebectasia: Usefulness of color Doppler ultrasonography in the diagnosis
H Shichinohe; S Kuroda; T Ishikawa; Y Iwasaki
NEUROLOGICAL SURGERY, 32, 1, 75, 78, Jan. 2004, [Peer-reviewed]
Japanese, Scientific journal - Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease
R Nanba; S Kuroda; M Takeda; H Shichinohe; N Nakayama; T Ishikawa; K Houkin; Y Iwasaki
NEUROLOGICAL SURGERY, 31, 12, 1291, 1295, Dec. 2003, [Peer-reviewed]
Japanese, Scientific journal - Normalization of cerebral hemodynamics and metabolism after carotid stenting in patients unfit for major surgery
D Kashiwazaki; S Kuroda; S Ushikoshi; H Shichinohe; T Ishikawa; T Asano; T Shiga; N Tamaki; Y Iwasaki
NEUROLOGICAL SURGERY, 31, 12, 1315, 1320, Dec. 2003, [Peer-reviewed]
Japanese, Scientific journal - 成人無症候性もやもや病の臨床像と予後
難波 理奈; 黒田 敏; 竹田 誠; 七戸 秀夫; 中山 若樹; 石川 達哉; 宝金 清博; 岩崎 喜信
Neurological Surgery, 31, 12, 1291, 1295, (株)医学書院, Dec. 2003
Japanese, 過去10年間に著者らが経験した成人無症候性もやもや病10例(男性4例,女性6例・平均年46.2歳)の臨床像,予後について検討した.脳MRIでは脳梗塞を3例に認め,梗塞部位はMCA-ACAあるいはMCA-PCA境界域,尾状核であった.DSAでは,全例病変は両側に存在し,鈴木の病期分類は30歳代で1〜3期が多く,50歳以降では4〜6期の例が多い傾向にあった.SPECTやPETによる脳循環代謝パラメータでは,内頸動脈領域の脳虚血を4例に認め,うち2例は脳梗塞を有した.平均4.1年間の経過観察中,1例でもやもや病の病期が進行し,脳梗塞を発症したが,その他の9例は経過観察期間中に脳虚血発作を呈した例はなく,うち1例は診断2年目に妊娠し,帝王切開にて無事出産した - Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice
JB Lee; S Kuroda; H Shichinohe; J Ikeda; T Seki; K Hida; M Tada; K Sawada; Y Iwasaki
NEUROPATHOLOGY, 23, 3, 169, 180, Sep. 2003, [Peer-reviewed]
English, Scientific journal - Three cases of successful stenting for radiation-induced carotid arterial stenosis
J Kitamura; S Kuroda; S Ushikoshi; K Furukawa; T Asano; H Shichinohe; K Houkin; Y Iwasaki; H Saitoh; K Mitsumori
NEUROLOGICAL SURGERY, 30, 10, 1097, 1102, Oct. 2002, [Peer-reviewed]
Japanese, Scientific journal - 放射線照射により生じた頸部頸動脈狭窄に対してステント留置術を行った3症例
北村 淳; 黒田 敏; 牛越 聡; 古川 浩司; 浅野 剛; 七戸 秀夫; 宝金 清博; 岩崎 喜信; 斉藤 久壽; 三森 研自
Neurological Surgery, 30, 10, 1097, 1102, (株)医学書院, Oct. 2002
Japanese, 舌癌或いは喉頭癌に対して放射線治療の既往があり,頸部内頸動脈狭窄症を認めた3例を対象とし,ステントを併用した血管形成術を施行した.ステントを併用した経皮的血管形成術(PTA)により,全ての病変において十分な狭窄の改善が得られた.狭窄率は,いずれも28%以下と著明に改善した.周術期に脳虚血症状は出現しなかった.経過観察期間中に,DSA又は頸動脈エコーにおいて明らかな再狭窄は認められず,新たな脳梗塞の再発も観察されなかった.合併症は1例で見られ,PTAを行った直後に痙攣が出現したが,その後,消失した - もやもや病の脳循環代謝 SPECT/PETによる検討
七戸 秀夫; 黒田 敏; 宝金 清博; 岩崎 喜信; 志賀 哲; 加藤 千恵次; 玉木 長良
脳循環代謝, 14, 1, 81, 81, (一社)日本脳循環代謝学会, Mar. 2002
Japanese - Spinal cord compression due to extramedullary hematopoiesis associated with polycythemia vera - Case report
Y Ohta; H Shichinohe; K Nagashima
NEUROLOGIA MEDICO-CHIRURGICA, 42, 1, 40, 43, Jan. 2002, [Peer-reviewed]
English, Scientific journal - 内頸動脈狭窄症に合併した"steal VBI"の2症例
七戸 秀夫; 黒田 敏; 宝金 清博; 牛越 聡; 岩崎 喜信; 阿部 弘
Neurological Surgery, 29, 9, 871, 876, (株)医学書院, Sep. 2001
Japanese, 視野障害を合併する内頸動脈高度狭窄症に対して,内頸動脈stent留置術を施行し,術前に低下していた後大脳動脈領域の脳血流量が増加し,症状が改善した症例を2例経験した.2例に共通する病態として,脳血管撮影では内頸動脈に高度狭窄が存在し,同側の後交通動脈が太く,これによって内頸動脈領域への側副血行路がよく発達していた.この為,SPECTでは反対側の後大脳動脈の脳血流量やacetazolamide反応性が低下し,その後頭葉に起因する視野狭窄を認めた.症例1(64歳男)では後頭葉に小さな脳梗塞もみられた.頸動脈狭窄症に対してstentを併用した経皮的血管形成術を実施したところ,後頭葉の脳循環が改善すると共に視野障害が軽快した.特に,症状の改善は脳梗塞を有さなかった症例2(64歳男)において顕著であった.いずれの症例においても椎骨動脈の起始部やその遠位部に閉塞性病変は認められなかった - Two cases of "steal VPI" with stenosis of the internal carotid artery
H Shichinohe; S Kuroda; K Houkin; S Ushikoshi; Y Iwasaki; H Abe
NEUROLOGICAL SURGERY, 29, 9, 871, 876, Sep. 2001, [Peer-reviewed]
Japanese, Scientific journal - 本態性血小板血症に合併した脳梗塞の2症例
七戸 秀夫; 黒田 敏; 宝金 清博; 岩崎 慶信; 布村 充
脳卒中, 23, 1, 136, 136, (一社)日本脳卒中学会, Mar. 2001
Japanese - 内頸動脈Stent術により,盗血現象による椎骨脳底動脈循環不全"steal VBI"が改善した2症例
七戸 秀夫; 黒田 敏; 宝金 清博; 阿部 弘; 菊池 陽一; 牛越 聡
脳卒中, 22, 1, 282, 282, (一社)日本脳卒中学会, Apr. 2000
Japanese - 頸動脈内膜剥離術と冠動脈バイパス術の一期的手術
七戸 秀夫; 黒田 敏; 石川 達哉; 宝金 清博; 阿部 弘; 松居 喜郎; 牛越 聡; 菊池 陽一
新潟医学会雑誌, 113, 11〜12, 575, 575, 新潟医学会, Dec. 1999
Japanese - 両側頸動脈病変と冠動脈病変を合併した1例
宝金 清博; 七戸 秀夫; 黒田 敏; 松居 喜朗; 牛越 聡
治療学, 33, 5, 582, 584, ライフサイエンス出版(株), May 1999
Japanese - 脳動脈瘤破裂による急性期くも膜下出血のMRI,MRA診断
青樹 毅; 金子 貞男; 七戸 秀夫; 宝金 清博; 阿部 弘; 三森 研自
日本脳神経外科学会総会抄録集, 56回, 28, 28, (一社)日本脳神経外科学会, Oct. 1997
Japanese
- 慢性期脳出血に対する間葉系幹細胞+足場材(CellSaic)の有効性
高宮宗一朗; 川堀真人; 北橋宗; 中村健太郎; 水野雄貴; 安井博宣; 久下裕司; 谷守亜紀; 高松泰行; 湯山耕平; 七戸秀夫; 藤村幹, 日本分子脳神経外科学会プログラム・抄録集, 22nd, 2022 - Cell Therapy against CNS Diseases : Current Status and Future Perspectives
川堀真人; 川堀真人; 七戸秀夫; 七戸秀夫; 黒田敏; 寳金清博, 脳神経外科ジャーナル, 29, 11, 777, 783, Nov. 2020Cell therapy for central nervous system (CNS) diseases including stroke, traumatic brain injury, spinal cord injury, and Parkinson's disease are now shifting from "basic research" to "clinical trials and approved therapies". The results obtained from the clinical research promise to alleviate CNS damage which have long been considered as unrecoverable. Autologous bone marrow derived mesenchymal stem cell product "Stemirac" was approved for insurance-covered therapy against acute spinal cord injury under the new Japanese regulation, and many more clinical trials focused especially on ischemic stroke are currently executed in Japan. However, there persist several unsolved issues including ideal cell types, transplantation routes, transplantation timing, and types of disease, which need to be clarified to maximize the effect of cell therapy. Hence, it is important for neurosurgeons to understand the current status of stem cell therapy as a treatment for patients suffering from CNS diseases.
, The Japanese Congress of Neurological Surgeons, Japanese - Cell therapy against central nervous disorders - Current and future perspectives -
川堀真人; 七戸秀夫; 黒田敏; 寳金清博, 神経治療学(Web), 37, 3, 2020 - Cell therapy against central nervous disorders – Current and future perspectives –
Kawabori Masahito; Shichinohe Hideo; Kuroda Satoshi; Houkin Kiyohiro, Neurological Therapeutics, 37, 3, 386, 390, 2020Stem cell therapy for central nervous system disorders have launched from basic research to the clinical trial phase. Many clinical trials are currently executed in Japan including ischemic stroke, traumatic brain injury, Parkingson's disease, and spinal cord injury. The preliminary data from these trials are promising and there is a strong expectation both from the medical and patient point of view. However, there are still so many unsolved questions which require further experimental procedures. The questions include cell types, transplantation route, transplantation timing and cell dosages. This article will highlight the basic knowledge of stem cell and the preliminary result of clinical trials launched in Japan.
, Japanese Society of Neurological Therapeutics, Japanese - 中枢神経疾患に対する細胞治療の現状と今後の展望 幹細胞で脳は治るのか?
川堀真人; 七戸秀夫; 山崎和義; 黒田敏; 寳金清博, 脳神経外科ジャーナル, 28, Supplement, 101, 20 Apr. 2019
Japanese - ラット亜急性期脊髄損傷モデルにおける骨髄間葉系幹細胞シートによる治療効果の検証
山崎和義; 川堀真人; 関俊隆; 七戸秀夫; 高宮宗一郎; 濱内祝嗣; 寳金清博; 寳金清博, 日本分子脳神経外科学会プログラム・抄録集, 20th, 2019 - 脳梗塞亜急性期に対する自家骨髄間質細胞の脳内投与 第一相治験:RAINBOW研究
川掘真人; 七戸秀夫; 黒田敏; 寳金清博, 脳循環代謝(Web), 31, 1, 2019 - 脳梗塞亜急性期に対する自家骨髄幹細胞の直接投与(第一相治験:RAINBOW研究)
川堀真人; 七戸秀夫; 七戸秀夫; 黒田敏; 寳金清博; 寳金清博, 神経治療学(Web), 36, 6, S128(J‐STAGE), 2019
Japanese - 脳梗塞に対する自家骨髄間質細胞直接投与第一相治験:RAINBOW研究
川堀真人; 七戸秀夫; 黒田敏; 寳金清博, 日本再生医療学会総会(Web), 18th, ROMBUNNO.O‐20‐6 (WEB ONLY), 2019
Japanese - 脳梗塞急性期に対する自家骨髄間質細胞(BMSC)移植治療 医師主導治験RAINBOW研究
川堀 真人; 七戸 秀夫; 山崎 和義; 黒田 敏; 寳金 清博, 脳循環代謝, 30, 1, 66, 66, Oct. 2018
日本脳循環代謝学会, Japanese - Brain Japanがめざす脳卒中治療への取り組み 脳梗塞に対する細胞療法
寳金 清博; 川堀 真人; 七戸 秀夫, 脳循環代謝, 30, 1, 71, 71, Oct. 2018
日本脳循環代謝学会, Japanese - Brain Japanがめざす脳卒中治療への取り組み 脳梗塞に対する細胞療法
寳金 清博; 川堀 真人; 七戸 秀夫, 脳循環代謝, 30, 1, 71, 71, Oct. 2018
日本脳循環代謝学会, Japanese - 脳梗塞急性期に対する自家骨髄間質細胞(BMSC)移植治療:医師主導治験RAINBOW研究
川堀真人; 七戸秀夫; 山崎和義; 黒田敏; 寳金清博, 脳循環代謝(Web), 30, 1, 66, 66, Oct. 2018
日本脳循環代謝学会, Japanese - 【(間葉系幹細胞の再生医療)】 脳梗塞に対する細胞治療 RAINBOW研究の取り組み
七戸 秀夫; 川堀 真人; 寳金 清博, レギュラトリーサイエンス学会誌, 8, 2, 115, 121, May 2018
(一社)レギュラトリーサイエンス学会, Japanese - 中国における中枢神経疾患に対する細胞治療の最新動向
王 子ほう; 譚 成博; 川堀 真人; 七戸 秀夫; 寶金 清博, 北海道医学雑誌, 93, 1, 13, 20, May 2018
オンライン上で、中枢神経再生の臨床試験に関する中国発の学術論文を検索した。網羅的に中枢神経系再生に関する臨床試験の論文は、英語379報、中国語3795報であった。中国発の幹細胞研究に関する臨床試験数は2012年初頭まで98であったが、2015年には244まで増加し、18試験が中枢神経系疾患に関する試験であった。中国において2015年末までに承認された幹細胞製品は10製品認め、5製品は中国の政府機関が申請しており、残りの5製品は中国企業によるものであった。最近(2015年7月20日)、中国国家食品薬品監督管理局(CFDA)が「幹細胞臨床研究管理方法(試行)」を発布したが、この法律が中国における幹細胞の管理方法に関する最初の規範となった。さらに2015年7月31日には、CFDAが「幹細胞製剤の品質管理及び臨床前指導原則」を発布している。, 北海道医学会, Japanese - 中国における中枢神経疾患に対する細胞治療の最新動向
王 子ほう; 譚 成博; 川堀 真人; 七戸 秀夫; 寶金 清博, 北海道医学雑誌, 93, 1, 13, 20, May 2018
オンライン上で、中枢神経再生の臨床試験に関する中国発の学術論文を検索した。網羅的に中枢神経系再生に関する臨床試験の論文は、英語379報、中国語3795報であった。中国発の幹細胞研究に関する臨床試験数は2012年初頭まで98であったが、2015年には244まで増加し、18試験が中枢神経系疾患に関する試験であった。中国において2015年末までに承認された幹細胞製品は10製品認め、5製品は中国の政府機関が申請しており、残りの5製品は中国企業によるものであった。最近(2015年7月20日)、中国国家食品薬品監督管理局(CFDA)が「幹細胞臨床研究管理方法(試行)」を発布したが、この法律が中国における幹細胞の管理方法に関する最初の規範となった。さらに2015年7月31日には、CFDAが「幹細胞製剤の品質管理及び臨床前指導原則」を発布している。, 北海道医学会, Japanese - 再生医療と病理 脳梗塞急性期に対する自家骨髄間質細胞(BMSC)移植治療 医師主導治験RAINBOW研究
川堀 真人; 七戸 秀夫; 山崎 和義; 黒田 敏; 寺坂 俊介; 寶金 清博, 日本病理学会会誌, 107, 1, 230, 230, Apr. 2018
(一社)日本病理学会, Japanese - 【脳梗塞超急性期診療】 脳血管障害患者に対する再生医療の現状と将来
川堀 真人; 七戸 秀夫; 黒田 敏; 宝金 清博, 日独医報, 62, 2, 161, 167, Jan. 2018
バイエル薬品(株), Japanese - 脳梗塞に対する自家骨髄間葉系幹細胞治療の医療経済学的検討
七戸秀夫; 七戸秀夫; 川堀真人; 寳金清博, 日本再生医療学会総会(Web), 17th, ROMBUNNO.O‐51‐6 (WEB ONLY), 2018
Japanese - Autologous Bone Marrow Stromal Cell Transplantation for Stroke: RAINBOW Project
七戸秀夫; 川堀真人; 寳金清博, レギュラトリーサイエンス学会誌, 8, 2, 115‐121(J‐STAGE), 121, 2018In recent years, the clinical application of regenerative medicine using stem cells has been heralded as a new approach to the treatment of cerebral infarction. Our translational researches about bone marrow stromal cells (BMSC) transplantation for stroke was supported by Initiative for Accelerating Regulatory Science in Innovative Drug, Medical Device, and Regenerative Medicine, which is the fund from Ministry of Health, Labour and Welfare in Japan, from 2012. Our on-going clinical trial, Research on Advanced Intervention using Novel Bone marrOW stem cell (RAINBOW) study, is a phase Ⅰ study for acute ischemic stroke and the first subject was enrolled in June 2017. Autologous BMSCs were cultured with human platelet lysate (PL), instead of fetal calf serum (FCS), in the cell processing center. The cells were transplanted around the infarct stereotactically. In advance, the donor cells were labeled with superparamagnetic iron oxide (SPIO) for cell tracking using MRI. After the transplantation, 18F-fluorodeoxyglucose (FDG) PET and 123I-Iomazenil SPECT were performed for the analysis of cellular function and brain metabolism. We expect that our study will evolve the autologous BMSC transplantation for stroke into the next generation. In the present article, we report our experience from the point of view of mechanisms of actions and therapeutic strategy, nonclinical studies, and subject screening in the clinical trials.
, Society for Regulatory Science of Medical Products, Japanese - 脳梗塞に対する自家骨髄間質細胞移植 RAINBOW研究
川堀 真人; 七戸 秀夫; 寺坂 俊介; 黒田 敏; 宝金 清博, 脳循環代謝, 29, 1, 158, 158, Nov. 2017
日本脳循環代謝学会, Japanese - ラット一過性脳虚血モデルに対する細胞治療:【18F】DPA‐714PETイメージングを用いた神経免疫反応の評価
七戸秀夫; 七戸秀夫; 譚成博; 譚成博; 趙松吉; 趙松吉; 東川桂; 王子豊; 川堀真人; 鐙谷武雄; 右近直之; 安井博宣; 玉木長良; 久下裕司; 寳金清博, 脳循環代謝(Web), 29, 1, 155, 155, Nov. 2017
日本脳循環代謝学会, Japanese - ラット一過性脳虚血モデルに対する細胞治療 [18F]DPA-714 PETイメージングを用いた神経免疫反応の評価
七戸 秀夫; 譚 成博; 趙 松吉; 東川 桂; 王 子豊; 川堀 真人; 鐙谷 武雄; 右近 直之; 安井 博宣; 玉木 長良; 久下 裕司; 寳金 清博, 脳循環代謝, 29, 1, 155, 155, Nov. 2017
日本脳循環代謝学会, Japanese - Challenges Identified in the Project for the Development of Human Cell Therapy Products in Hokkaido University: Mid-term Review
沢登健治; 佐久嶋研; 荒戸照世; 七戸秀夫; 七戸秀夫; 佐藤典宏; 寳金清博; 寳金清博, レギュラトリーサイエンス学会誌, 7, 2, 91‐97(J‐STAGE), 97, May 2017
(一社)レギュラトリーサイエンス学会, Japanese - ELSI research in cell therapy for stroke
七戸 秀夫, 医学のあゆみ, 260, 7, 600, 604, 18 Feb. 2017
医歯薬出版, Japanese - 脳梗塞に対する自家骨髄間質細胞移植:RAINBOW研究
川堀真人; 七戸秀夫; 譚成博; 王子ほう; 鐙谷武雄; 中山若樹; 数又研; 宝金清博, 再生医療, 16, 273, 01 Feb. 2017
Japanese - Preface
Kiyohiro Houkin; Hideo Shichinohe, Cell Therapy against Cerebral Stroke: Comprehensive Reviews for Translational Researches and Clinical Trials, v, vii, 01 Jan. 2017
Springer Japan, English, Others - 自家骨髄間質細胞移植による脳梗塞再生医療をめざして
七戸秀夫; 寳金清博, 日本神経学会学術大会プログラム・抄録集, 57th, Suppl., 176, S47, Dec. 2016
(一社)日本神経学会, Japanese - 全身麻酔下頸動脈ステント留置術の有用性と術中モニタリング
月花 正幸; 青樹 毅; 長内 俊也; 中山 若樹; 数又 研; 鐙谷 武雄; 七戸 秀夫; 寳金 清博, 脳血管内治療, 1, Suppl., S224, S224, Nov. 2016
(NPO)日本脳神経血管内治療学会, Japanese - 再生医療の基礎と臨床UP to DATE 脳梗塞に対する自家骨髄間質細胞移植
七戸 秀夫; 寳金 清博, 脳循環代謝, 28, 1, 124, 124, Nov. 2016
日本脳循環代謝学会, Japanese - 部分血栓化動脈瘤による三叉神経痛様の眼周囲痛に対しステント併用コイル塞栓術が著効した1例
月花正幸; 長内俊也; 数又研; 牛越聡; 高宮宗一郎; 斉藤巧実; 中山若樹; 七戸秀夫; 鐙谷武雄; 宝金清博, 脳神経外科速報, 26, 5, 515‐521, 521, 10 May 2016
症例は30歳代女性で、6ヵ月前、頭痛を主訴に受診し、類もやもや病と右後大脳動脈(PCA)血栓化動脈瘤と診断され経過観察となった。1ヵ月前より、突発的な右眼周囲痛の激しい痛みが出現し、動脈瘤の明らかな増大を認めた。三叉神経痛様の右眼周囲痛に対して、カルバマゼピンを処方し軽度症状の改善を認めた。急速な動脈瘤の増大と新たな脳神経障害を認めているため手術の方針となった。片側の類もやもや病と右PCAの下向き大型部分血栓化動脈瘤の診断にて、EC-IC bypass併用の血管内母血管閉塞術を試みた。術2週間後にステント併用コイル塞栓術を施行した。術翌日から右眼周囲の疼痛は消失し、カルバマゼピンは休薬した。術後9ヵ月後のMRIでは若干の血栓化瘤の縮小を認め、疼痛の再発は認めない。, (株)メディカ出版, Japanese - 小児もやもや病の外科的治療の現状と課題
数又研; 内野晴登; 中山若樹; 七戸秀夫; 鐙谷武雄; 寶金清博, 脳神経外科ジャーナル, 25, Supplement, 80, 20 Apr. 2016
Japanese - アカデミアにおける再生医療製品の開発プロジェクトの中間レビューにより抽出された課題
沢登健治; 佐久嶋研; 荒戸照世; 七戸秀夫; 佐藤典宏; 寶金清博; 寶金清博, 再生医療, 15, 310, 01 Feb. 2016
Japanese - ラット脳梗塞モデルにおける全身炎症所見~骨髄間質細胞(BMSC)移植による中枢神経再生治療のために
譚成博; WANG Zifeng; 濱内祝嗣; 鐙谷武雄; 中山若樹; 数又研; 穂刈正昭; 七戸秀夫; 寶金清博, 再生医療, 15, 291, 01 Feb. 2016
Japanese - 脳梗塞に対する自家骨髄間質細胞移植:MSC2.0
七戸秀夫; 譚成博; 濱内祝嗣; 王子豊; 鐙谷武雄; 中山若樹; 数又研; 寳金清博, 再生医療, 15, 268, 01 Feb. 2016
Japanese - In vivo Tracking of Bone Marrow Stromal Cells Using 111 Inoxine Labeling and SPECT Following Transplantation for Cerebral Infarct of Rats
Hisayasu Saito; Satoshi Kuroda; Songji Zhao; Naoki Kubo; Yuji Kuge; Nagara Tamaki; Hideo Shichinohe; Kiyohiro Houkin, Stroke, 47, suppl 1, TP99, Feb. 2016
English, Summary international conference - 脳梗塞に対する自家骨髄間質細胞移植
七戸秀夫; 寳金清博, 脳循環代謝(Web), 28, 1, 2016 - 全身麻酔下頸動脈ステント留置術の有用性と術中モニタリング
月花正幸; 青樹毅; 長内俊也; 中山若樹; 数又研; 鐙谷武雄; 七戸秀夫; 寳金清博, 脳血管内治療(Web), 1, Supplement, S224(J‐STAGE), 2016
Japanese - 部分血栓化動脈瘤による眼周囲痛に対しステント併用コイル塞栓術が著効した1例
月花正幸; 長内俊也; 数又研; 牛越聡; 高宮宗一郎; 斉藤巧実; 中山若樹; 七戸秀夫; 鐙谷武雄; 寶金清博, Journal of Neuroendovascular Therapy, 9, 6, S374, 02 Nov. 2015
Japanese - アカデミアにおける再生医療製品の開発プロジェクトの中間レビューにより抽出された課題
沢登健治; 佐久嶋研; 荒戸照世; 七戸秀夫; 佐藤典宏; 寶金清博; 寶金清博, レギュラトリーサイエンス学会誌, 5, Supplement, 73, Aug. 2015
Japanese - もやもや病iPS細胞由来血管内皮細胞におけるangiogenic factorへの反応性の解析
浜内祝嗣; 七戸秀夫; 伊東雅基; 長内俊也; 穂刈正昭; 中山若樹; 数又研; 江良択実; 寶金清博, 再生医療, 14, 214, 01 Feb. 2015
Japanese - 自家骨髄細胞移植による脳梗塞再生医療をめざして:他家ヒトplatelet lysateを用いたヒト骨髄間質細胞培養
譚成博; 七戸秀夫; 濱内祝嗣; 鐙谷武雄; 中山若樹; 数又研; 穂刈正昭; 寶金清博, 再生医療, 14, 360, 01 Feb. 2015
Japanese - 脳梗塞に対する自家骨髄間質細胞移植:次世代の再生医療を目指して
七戸秀夫; 譚成博; 濱内祝嗣; 鐙谷武雄; 中山若樹; 数又研; 穂刈正昭; 寳金清博, 再生医療, 14, 302, 01 Feb. 2015
Japanese - 未破裂脳動脈瘤の病理所見:動脈瘤の発生から破裂へのプロセスと頭痛の関連を探る試み
穂刈正昭; 穂刈正昭; 中山若樹; 下田祐介; 鐙谷武雄; 七戸秀夫; 寳金清博, 日本脳循環代謝学会総会プログラム・抄録号, 27th, 141, 2015
Japanese - Hereditary hemorrhagic telangiectasiaに合併したdenovo AVM
下田祐介; 長内俊也; 中山若樹; 牛越聡; 内野晴登; 栗栖宏多; 穂刈正昭; 七戸秀夫; 鐙谷武雄; 数又研; 寶金清博, J Neuroendovascular Ther, 8, 6, 369, 01 Dec. 2014
Japanese - 脳血管造影検査・血管内治療におけるエコーガイド下大腿動脈穿刺の有用性
栗栖宏多; 長内俊也; 下田祐介; 鐙谷武雄; 数又研; 中山若樹; 七戸秀夫; 穂刈正昭; 牛越聡; 宝金清博, J Neuroendovascular Ther, 8, 6, 203, 203, 01 Dec. 2014
(NPO)日本脳神経血管内治療学会, Japanese - 全身血管病に起因する頸部内頸動脈解離性動脈瘤対してStent assisted coil embolizationが有効であった一例
高宮宗一朗; 長内俊也; 牛越聡; 栗栖宏多; 下田祐介; 伊藤康裕; 伊師雪友; 中山若樹; 数又研; 鐙谷武雄; 七戸秀夫; 寶金清博, J Neuroendovascular Ther, 8, 6, 434, 01 Dec. 2014
Japanese - 血友病Aを合併した無症候性椎骨動脈紡錘状脳動脈瘤に血管内治療を施行した一例
岡本迪成; 長内俊也; 栗栖宏多; 下田祐介; 中山若樹; 数又研; 鐙谷武雄; 七戸秀夫; 寶金清博, J Neuroendovascular Ther, 8, 6, 396, 01 Dec. 2014
Japanese - 脳虚血再灌流傷害に対する人工酸素運搬体の経動脈的投与による治療戦略
鐙谷武雄; 新保大輔; 七戸秀夫; 中山若樹; 数又研; 宝金清博, 人工血液, 22, 1, 33, 33, 20 Nov. 2014
日本血液代替物学会, Japanese - スパズムにおけるTranspulmonary thermodilution catheterを用いた体液循環管理
数又研; 武藤達士; 横山由佳; 中山若樹; 七戸秀夫; 新保大輔; 斎藤泰弘; 栗栖宏多; 宝金清博, 脳血管れん縮, 29, 27, 30, 28 Feb. 2014
破裂脳動脈瘤の治療を行った58例を対象に、thermistor catheter挿入によるbedside monitoring systemで得られた体液循環動態の指標について検討した。コイル塞栓術施行群とクリッピング術施行群でcardiac index(CI)、global endodiastolic volume index(GEDI)、extravascular lung water index(EVLWI)の平均値に有意差はなく、GEDIが異常値を示す頻度はクリッピング群で有意に高かった。day 0〜7のGEDIはクリッピング術で正常値下限を下回る頻度が高く、day 8〜14のCIはday 0〜7に比較してクリッピング術により正常値を逸脱する頻度が高かった。たこつぼ心筋を続発した症例は、day 0〜1では循環動態の指標は正常下限で、day 2〜5にcardiac depressionが観察され、回復期を経てday 8〜10に正常化した。回復期にはCIやGEDI値が増加し続け、day 10付近では急速に低下してエコー上の心筋の運動の正常化と一致した。, スパズム・シンポジウム事務局, Japanese - SPIOでラベリングした骨髄間質細胞,脳梗塞再生医療のソースとしての長期安全性
譚成博; 七戸秀夫; 寳金清博, 再生医療, 13, 2014 - Platelet lysateで培養した骨髄間質細胞移植による脳梗塞再生医療
七戸秀夫; 寳金清博, 血液事業, 36, 4, 2014 - Bioimaging in Cell Transplantation Therapy for Stroke
七戸秀夫; 寳金清博; 黒田敏, 日本磁気共鳴医学会雑誌, 34, 2, 2014 - Steps to the Clinical Testing of Bone Marrow Stromal Cell Transplantation for Stroke
七戸秀夫; 寳金清博, 神経治療学, 31, 3, 2014 - 自家骨髄細胞移植による脳梗塞再生医療をめざして:日本発の前臨床/臨床試験ガイドラインの必要性
七戸秀夫; 寳金清博, 再生医療, 13, 2014 - 脳梗塞に対する細胞治療,その神経保護効果について
七戸秀夫; 寳金清博; 黒田敏, 日本脳循環代謝学会総会プログラム・抄録号, 26th, 2014 - SPIOでラベリングした他家骨髄間質細胞の脳内投与による安全性
譚成博; 七戸秀夫; 鐙谷武雄; 中山若樹; 数又研; 穂刈正昭; 浜内祝嗣; 寳金清博, 日本脳循環代謝学会総会プログラム・抄録号, 26th, 2014 - 治療戦略を目指した研究 再生・移植基礎研究 脳虚血後の神経再生
七戸秀夫; 寳金清博, 日本臨床, 72, 2014 - マウス局所脳虚血モデルに対する,シロスタゾールのROS産生抑制作用を介した脳保護効果
七戸秀夫; 鐙谷武雄; 中山若樹; 数又研; 穂刈正昭; 譚成博; 寳金清博; 黒田敏, 日本脳循環代謝学会総会プログラム・抄録号, 26th, 2014 - Neuroprotective effect of liposome-encapsulated hemoglobin as an artificial oxygen carrier
新保大輔; 新保大輔; 鐙谷武雄; 七戸秀夫; 中山若樹; 数又研; 宝金清博; 石塚隆伸, 脳循環代謝(Web), 25, 2, 51‐55 (J‐STAGE), 2014
Japanese - Neuroprotective effect of liposome-encapsulated hemoglobin as an artificial oxygen carrier
Shimbo Daisuke; Abumiya Takeo; Shichinohe Hideo; Nakayama Naoki; Kazumata Ken; Houkin Kiyohiro; Ishizuka Takanobu, Cerebral Blood Flow and Metabolism (Japanese journal of cerebral blood flow and metabolism), 25, 2, 51, 55, 2014
In the present study we examine whether the intra-arterial infusion of liposome-encapsulated hemoglobin (LEH) via the recanalized internal carotid artery can have the neuroprotective effect on ischemia-reperfusion (I/R) injury by using transient middle cerebral artery occlusion model of rats. Neurological function was significantly improved and infarct and edema area were significantly reduced in the LEH treatment group. LEH was distributed in more microvessels compared with rat erythrocyte. Because of its small size, LEH can effectively deliver oxygen to narrow microvessels. This advantage may contribute to the inhibition of endothelial damage, and, moreover, the inhibition of neutrophil activation, neutrophil-derived matrix metalloprotease-9 production, and the breakdown of blood-brain barrier. The intra-arterial infusion of LEH may be a promising candidate to prevent I/R injury after thrombolysis and/or thrombectomy., 日本脳循環代謝学会, Japanese - Alteration in Gene Expression Profiles in Aging Cerebral Cortex Prior to the Occurrence of Stroke in Stroke-Prone Spontaneously Hypertensive Rats
Masaki Ito; Satoshi Kuroda; Koji Takahashi; Masahito Kawabori; Michiyuki Miyamoto; Tomohiro Yamauchi; Hisayasu Saito; Hideo Shichinohe; Kiyohiro Houkin, STROKE, 44, 2, Feb. 2013
English, Summary international conference - Bone Marrow Stromal Cells Enhance The Recovery of Peri-infarct Neuronal Integrity by Replacing The Damaged Neurons - A Serial I-123-Iomazenil SPECT Study
Saito Hisayasu; Kuroda Satoshi; Miyamoto Michiyuki; Yamauchi Tomohiro; Shichinohe Hideo; Zhao Songji; Magota Keiichi; Kubo Naoki; Kuge Yuji; Tamaki Nagara; Houkin Kiyohiro, STROKE, 44, 2, Feb. 2013, [Peer-reviewed] - Platelet lysateで培養した骨髄間質細胞移植による脳梗塞再生医療
七戸秀夫; 寳金清博, 血液事業, 36, 2, 2013 - 骨髄間質細胞移植による脳梗塞再生医療:治療機序の分子細胞レベルでの検討
七戸秀夫; 山内朋裕; 斎藤久泰; 寳金清博; 黒田敏, 脳循環代謝, 25, 1, 2013 - 自家骨髄間質細胞移植による脳梗塞再生医療をめざして
七戸秀夫; 寳金清博, 神経治療学, 30, 5, 2013 - 脳梗塞治療のための自己骨髄間質細胞移植
七戸秀夫; 寳金清博, 週刊日本医事新報, 4663, 2013 - 人工酸素運搬体liposome‐encapsulated hemoglobinの脳保護効果
新保大輔; 鐙谷武雄; 七戸秀夫; 中山若樹; 数又研; 石塚隆伸; 宝金清博, 脳循環代謝, 25, 1, 105, 105, 2013
(一社)日本脳循環代謝学会, Japanese - ASL‐4D MRAを用いたもやもや病患者の周術期血行動態評価
内野晴登; 伊東雅基; 数又研; 中山若樹; 藤間憲幸; 七戸秀夫; 鐙谷武雄; 宝金清博, 脳循環代謝, 25, 1, 147, 147, 2013
(一社)日本脳循環代謝学会, Japanese - Ratにおける虚血再灌流障害に対する局所低脳温治療の有効性の検討
栗栖宏多; 鐙谷武雄; 新保大輔; 下田祐介; 七戸秀夫; 中山若樹; 数又研; 宝金清博, 脳循環代謝, 25, 1, 172, 172, 2013
(一社)日本脳循環代謝学会, Japanese - 無症候性もやもや病におけるFLAIR′′ivy sign′′の頻度と脳循環代謝
伊東雅基; 栗栖宏多; SANDRA Vuignier; 数又研; 中山若樹; 七戸秀夫; 志賀哲; 玉木長良; 宝金清博, 脳循環代謝, 25, 1, 146, 146, 2013
(一社)日本脳循環代謝学会, Japanese - もやもや病の病態における,循環血液中の血管内皮前駆細胞の意義
七戸秀夫; 杉山拓; 濱内祝嗣; 数又研; 中山若樹; 寳金清博; 黒田敏, 脳循環代謝, 25, 1, 148, 148, 2013
(一社)日本脳循環代謝学会, Japanese - t‐PA静注療法1時間後のSPECTイメージングによる予後評価
鐙谷武雄; 加藤正仁; 森脇拓也; 吉野雅美; 青樹毅; 今村博幸; 会田敏光; 七戸秀夫; 中山若樹; 数又研; 宝金清博, 脳循環代謝, 25, 1, 163, 163, 2013
(一社)日本脳循環代謝学会, Japanese - ウイリス動脈輪閉塞症の診断・治療に関する研究 当科における複合血行再建術の周術期合併症とSystematic Review
伊東雅基; 数又研; 中山若樹; 七戸秀夫; 宝金清博, ウイリス動脈輪閉塞症の診断・治療に関する研究 平成24年度 総括・分担研究報告書, 6, 12, 2013
Japanese - ウイリス動脈輪閉塞症の診断・治療に関する研究 もやもや病患者のEPC研究(第2報)とiPS細胞系確立に向けて
宝金清博; 七戸秀夫; 伊東雅基; 数又研; 中山若樹, ウイリス動脈輪閉塞症の診断・治療に関する研究 平成24年度 総括・分担研究報告書, 3, 5, 2013
Japanese - Bone marrow stromal cell transplantation enhances recovery of local glucose metabolism after cerebral infarct in rats : A serial [18]F-FDG PET study
宮本 倫行; 黒田 敏; 趙 松吉; 孫田 恵一; 伊東 雅基; 川堀 真人; 七戸 秀夫; 宝金 清博; 久下 裕司; 玉木 長良, 北海道醫學雜誌 = Acta medica Hokkaidonensia, 87, 6, 269, 269, 01 Nov. 2012
Japanese - もやもや病の病態と治療 最新の知見 もやもや病の病態における、循環血液中の血管内皮前駆細胞の意義
七戸 秀夫; 黒田 敏; 杉山 拓; 寳金 清博, 脳循環代謝, 23, 2, 106, 106, Sep. 2012
日本脳循環代謝学会, Japanese - 骨髄間質細胞移植は脳梗塞後の局所糖代謝を改善する―小動物用PET/CTによる検討
宮本倫行; 黒田敏; 趙松吉; 孫田恵一; 伊東雅基; 川堀真人; 七戸秀夫; 宝金清博; 久下裕司; 玉木長良, 核医学, 49, 3, 214, S194, 31 Aug. 2012
(一社)日本核医学会, Japanese - 骨髄間質細胞移植は脳梗塞周囲の神経受容体機能を改善させる―123I‐iomazenil SPECTによる検討
齋藤久泰; 黒田敏; 黒田敏; 宮本倫行; 山内朋裕; 七戸秀夫; 趙松吉; 孫田惠一; 久保直樹; 久下裕司; 寶金清博; 玉木長良, 核医学, 49, 3, 214, 31 Aug. 2012
Japanese - ラット脳梗塞亜急性期モデルに対する骨髄間質細胞の直接投与と経静脈投与 : 光イメージングによる検討
川堀 真人; 黒田 敏; 杉山 拓; 七戸 秀夫; 宝金 清博; 久下 裕司; 玉木 長良, 北海道醫學雜誌 = Acta medica Hokkaidonensia, 87, 4, 205, 205, 01 Aug. 2012
Japanese - ラット脳凍結損傷モデルに対する骨髄間質細胞の経動脈的移植 : 生体蛍光イメージング法による評価
長内 俊也; 黒田 敏; 七戸 秀夫; 杉山 拓; 久下 裕司; 宝金 清博; 玉木 長良; 岩崎 喜信, 北海道醫學雜誌 = Acta medica Hokkaidonensia, 87, 4, 206, 206, 01 Aug. 2012
Japanese - 骨髄間質細胞移植は脳梗塞周囲の受容体機能を改善させる―123I‐iomazenil SPECTによる検討
齋藤久泰; 黒田敏; 宮本倫行; 山内朋裕; 新保大輔; 七戸秀夫; 趙松吉; 孫田惠一; 久保直樹; 久下裕司; 玉木長良; 寶金清博, 再生医療, 11, 191, 16 May 2012
Japanese - Recent Progress and Perspective in Management of Moyamoya Disease
KURODA Satoshi; SUGIYAMA Taku; KAWABORI Masahito; SASAMORI Tohru; KURISU Kota; UCHINO Haruto; SHICHINOHE Hideo; NAKAYAMA Naoki; HOUKIN Kiyohiro, Surgery for Cerebral Stroke, 40, 2, 77, 82, Mar. 2012
(一社)日本脳卒中の外科学会, Japanese - 骨髄間質細胞移植による中枢神経再生医療のトランスレーショナルリサーチ
七戸秀夫; 黒田敏; 山内朋裕; 齋藤久泰; 新保大輔; 寳金清博, 脳循環代謝, 24, 1, 2012 - 骨髄間質細胞移植による“Nursing Effect”-神経栄養因子の分泌による神経保護作用
七戸秀夫; 石原武; 黒田敏; 高橋浩治; 田中嘉一; 宮本倫行; 山内朋裕; 斎藤久泰; 武本浩; 寳金清博, 再生医療, 11, 2012 - もやもや病の病態と治療 最新の知見 もやもや病の病態における、循環血液中の血管内皮前駆細胞の意義
七戸 秀夫; 黒田 敏; 杉山 拓; 寳金 清博, 脳循環代謝, 23, 1, 97, 97, Nov. 2011
日本脳循環代謝学会, Japanese - Transplanted Bone Marrow Stromal Cells Protect Neurovascular Units and Ameliorate Brain Damage in Stroke-Prone Spontaneously Hypertensive Rats
Masaki Ito; Satoshi Kuroda; Taku Sugiyama; Katsuhiko Maruichi; Masahito Kawabori; Hideo Shichinohe; Kiyohiro Houkin, STROKE, 42, 3, E94, E95, Mar. 2011
English, Summary international conference - Bone Marrow Stromal Cell Transplantation Attenuates Cognitive Dysfunction Due to Chronic Cerebral Ischemia in Rats
Hideo Shichinohe; Satoshi Kuroda; Taku Sugiyama; Masaki Ito; Masahito Kawabori, STROKE, 42, 3, E68, E68, Mar. 2011
English, Summary international conference - 臨床用MRIをもちいた,鉄製剤で標識された骨髄間質細胞のファントム内検出
七戸秀夫; 黒田敏; 工藤與亮; 伊東雅基; 川堀真人; 宮本倫行; 宝金清博; 寺江聡, 再生医療, 10, 257, 01 Feb. 2011
Japanese - Autologous bone marrow stromal cell transplantation for central nervous system disorders - recent progress and perspective for clinical application
Satoshi Kuroda; Hideo Shichinohe; Kiyohiro Houkin; Yoshinobu Iwasaki, Journal of Stem Cells and Regenerative Medicine, 7, 1, 2, 13, 2011
English, Book review - Progress and perspective of bone marrow stromal cell transplantation for ischemic stroke
KURODA Satoshi; SHICHINOHE Hideo; SUGIYAMA Taku; ITO Masaki; KAWABORI Masato; CHIBA Yasuhiro; OSANAI Toshiya; MARUICHI Katsuhiko; HOUKIN Kiyohiro; IWASAKI Yoshinobu, Nosotchu, 32, 6, 532, 537, 25 Nov. 2010
第35回日本脳卒中学会 シンポジウム1 総説, The Japan Stroke Society, Japanese - 血清を用いずに培養したヒト骨髄間質細胞のラット脳梗塞モデルへの移植およびMRIによる移植細胞追跡
伊東 雅基; 黒田 敏; 杉山 拓; 七戸 秀夫; 武田 紫; 西尾 充史; 小池 隆雄; 寶金 清博, 脳循環代謝, 22, 1, 128, 128, Nov. 2010
日本脳循環代謝学会, Japanese - 脳梗塞をターゲットとした再生医療における最適な細胞移植法
川堀 真人; 黒田 敏; 七戸 秀夫; 宝金 清博, 再生医療, 9, 4, 477, 486, Nov. 2010
(株)メディカルレビュー社, Japanese - Platelet lysateを用いたヒト骨髄間質細胞培養 安全な中枢神経再生の臨床応用を目指して
七戸 秀夫; 黒田 敏; 杉山 拓; 伊東 雅基; 川堀 真人; 西尾 充史; 武田 紫; 小池 隆夫; 寳金 清博, 脳循環代謝, 22, 1, 128, 128, Nov. 2010
日本脳循環代謝学会, Japanese - ヒト骨髄間質細胞の安全で効率的な培養法 骨髄間質細胞移植による中枢神経再生の臨床応用にむけて
伊東 雅基; 黒田 敏; 杉山 拓; 七戸 秀夫; 武田 紫; 西尾 充史; 小池 隆夫; 寶金 清博, 再生医療, 9, 3, 385, 392, Aug. 2010
(株)メディカルレビュー社, Japanese - Bone Marrow Stromal Cells and Bone Marrow-derived Mononuclear Cells: Which Are Suitable as Cell Source of Transplantation for Mice Infarct Brain?
Hideo Shichinohe; Satoshi Kuroda; Katsuhiko Maruichi; Toshiya Osanai; Taku Sugiyama; Yasuhiro Chiba; Ayumi Yamaguchi; Yoshinobu Iwasaki, STROKE, 41, 4, E232, E232, Apr. 2010
English, Summary international conference - ヒト骨髄間質細胞(hBMSC)のラット脳梗塞における治療効果の検討
杉山拓; 黒田敏; 七戸秀夫; 伊東雅基; 川堀真人; 武田紫; 西尾充史, 再生医療, 9, 2010 - ラット大脳凍結損傷モデルへの骨髄間質細胞の動注移植
長内 俊也; 黒田 敏; 千葉 泰弘; 丸一 勝彦; 杉山 拓; 安田 宏; 七戸 秀夫; 岩崎 喜信, 日本神経外傷学会プログラム・抄録集, 32回, 043, 043, Apr. 2009
(一社)日本脳神経外傷学会, Japanese - 骨髄間質細胞(BMSC)の移植はびまん性軸策損傷(DAI)による高次脳機能障害を改善する 11C-FMZ PET/CTを用いた検討
丸一 勝彦; 黒田 敏; 千葉 泰弘; 長内 俊也; 穂刈 正昭; 杉山 拓; 七戸 秀夫; 岩崎 喜信, 日本神経外傷学会プログラム・抄録集, 32回, 045, 045, Apr. 2009
(一社)日本脳神経外傷学会, Japanese - 長波長蛍光物質で標識した骨髄間質細胞(BMSC)の頭蓋内蛍光イメージング
杉山拓; 黒田敏; 長内俊也; 千葉泰弘; 丸一勝彦; 七戸秀夫; 久下裕司; 岩崎喜信, 日本脳神経外科学会総会抄録集(CD-ROM), 68th, 2009 - マウス骨髄由来単核細胞の脳虚血モデルへの移植-移植ソースとしての骨髄間質細胞との比較
七戸秀夫; 黒田敏; 丸一勝彦; 長内俊也; 杉山拓; 千葉泰弘; 山口明弓; 岩崎喜信, 日本脳神経外科学会総会抄録集(CD-ROM), 68th, 2009 - Mouse model of focal cerebral ischemia using endothelin-1
Nobutaka Horie; Hideo Shichinohe; Tonya Bliss; Gary K. Steinberg, JOURNAL OF NEUROSURGERY, 109, 2, A368, A369, Aug. 2008
English, Summary international conference - Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct
Hideo Shichinohe; Satoshi Kuroda; Shunsuke Yano; Kazutoshi Hida; Yoshinobu Iwasaki, STROKE, 39, 2, 660, 660, Feb. 2008
English, Summary international conference - Ischemia-induced angiogenesis is enhanced by hCNS-SCn transplantation
Nobutaka Horie; Tonya Bliss; Hideo Shichinohe; Theo Palmer; Gary Steinberg, STROKE, 39, 2, 658, 658, Feb. 2008
English, Summary international conference - Timing of MGE cell transplantation after distal middle cerebral artery occlusion significantly influences the cell-host interaction
Hideo Shichinohe; Marcel M. Daadi; Nobutaka Horie; Theo D. Palmer; Tonya Bliss; Gary K. Steinberg, STROKE, 39, 2, 534, 534, Feb. 2008
English, Summary international conference - 3.骨髄間質細胞を用いた損傷脊髄の再生(再生医療:脊髄移植の現状と課題,パネルディスカッション3,特別企画,実学としてのリハビリテーションの継承と発展,第44回日本リハビリテーション医学会学術集会)
黒田 敏; 穂刈 正昭; 七戸 秀夫; 矢野 俊介; 飛騨 一利; 岩崎 喜信, リハビリテーション医学 : 日本リハビリテーション医学会誌, 44, 0, S127, 18 May 2007
社団法人日本リハビリテーション医学会, Japanese - Recent Strategies and Results for Asymptomatic Severe Carotid Artery Stenosis Complicated with Coronary, Valvular, or Aortic Disorder(
Treatment Strategies for Asymptomatic Carotid Stenosis)
KURODA Satoshi; TERASAKA Shunsuke; ISHIKAWA Tatsuya; USHIKOSHI Satoshi; KASHIWAZAKI Daina; SHICHINOHE Hideo; ASANO Takeshi; NUNOMURA Mitsuru; ABUMIYA Takeo; IWASAKI Yoshinobu, Surgery for cerebral stroke, 34, 5, 323, 327, 30 Sep. 2006
We review our recent results in 18 patients with asymptomatic severe (75%<) carotid artery stenosis complicated with coronary, valvular, or aortic disorder that requires surgical treatments. According to our treatment protocol, 4 patients underwent carotid endarterectomy (CEA) and coronary artery bypass graft (CABG) or off-pump CABG (OPCABG) simultaneously. Ten patients underwent 2-staged therapy including CEA or carotid artery stenting (CAS) and cardiovascular surgery. CEA following OPCABG was selected in 2 patients with 75% carotid artery stenosis. Two other complicated patients required ..., The Japanese Conference on Surgery for Cerebral Stroke, Japanese - Bone marrow stromal cells promote the neurite extension in organotypic spinal cord slice
H Shichinohe; S Kuroda; S Tsuji; S Yamaguchi; S Yano; JB Lee; H Kobayashi; S Kikuchi; K Hida; Y Iwasaki, JOURNAL OF NEUROSURGERY, 104, 4, A664, A665, Apr. 2006
English, Summary international conference - Analysis of Subarachnoid Hemorrhage by Using the Japanese Stroke Data Bank : National and Regional Investigation on Age, Gender, and Prognosis of Subarachnoid Hemorrhage
ABUMIYA Takeo; SHICHINOHE Hideo; KURODA Satoshi; ISHIKAWA Tatusya; IWASAKI Yoshinobu; KOBAYASHI Shoutai; Japan Standar; Stroke Registry; Study Group, Surgery for cerebral stroke, 34, 1, 49, 53, 31 Jan. 2006
We explored national and regional characteristics based on age, gender, and prognosis of subarachnoid hemorrhage by using the Japanese Stroke Data Bank, a data bank of acute stroke patients established to provide evidence for standardization of Japanese stroke management. We analyzed data from 1,183 patients with subarachnoid hemorrhage in the Japanese Stroke Data Bank. For regional investigation, we divided the patients into 3 groups according to their place of residence : Hokkaido, Tohoku, and the area west of Kanto. The total male-to-female ratio was 1:1.88. The female proportion was dom..., The Japanese Conference on Surgery for Cerebral Stroke, Japanese - 骨髄間質細胞を用いた神経再生医療の研究と今後の臨床応用
穂刈正昭; 黒田敏; 七戸秀夫; 矢野俊介; 山口智; 安田宏; 井戸坂弘之; 中山若樹; 池田潤; 飛騨一利; 岩崎喜信, 日本脳神経外科学会総会抄録集(CD−ROM), 65th, S10-3, 2006
Japanese - Pitfalls and Their Recent Progress Countermeasure in Carotid Endarterectomy : Recent Progress
KURODA Satoshi; ISHIKAWA Tatsuya; TERASAKA Shunsuke; USHIKOSHI Satoshi; SHICHINOHE Hideo; ASANO Takeshi; KASHIWAZAKI Daina; ABUMIYA Takeo; IWASAKI Yoshinobu, Surgery for cerebral stroke, 33, 3, 174, 179, 31 May 2005
We review our recent experience of carotid endarterectomy (CEA) for 30 patients wit severe carotid artery stenosis. In this report, we emphasize the importance of critical management before, during, and after surgery to reduce or remove the incidence of perioperative complications Especially, we should carefully manage the patients who are at higher risk for hyperperfusion syndrome and those with complications of serious coronary artery disease. We also describe our surgical technique and results., The Japanese Conference on Surgery for Cerebral Stroke, Japanese - 脳梗塞再発例における発症前MRI/MRA所見の後ろ向き検討
鐙谷武雄; 阿部悟; 斉藤久寿; 七戸秀夫; 黒田敏; 石川達哉; 岩崎喜信, 脳卒中, 27, 1, 149, 01 Apr. 2005
Japanese - Current and future overview of moyamoya disease
KURODA Satoshi; NAKAYAMA Naoki; NANBA Rina; SHICHINOHE Hideo; ISHIKAWA Tatsuya; SUZUKI Akifumi; NISHINO Akiko; HOUKIN Kiyohiro; MINEMATSU Kazuo, Nosotchu, 25, 2, 215, 229, 25 Jun. 2003
Japanese - FK506 ameliorates infarct volume due to permanent middle cerebral artery occlusion in mice
H Shichinohe; S Kuroda; K Houkin; Y Iwasaki, STROKE, 33, 1, 407, 407, Jan. 2002
English, Summary international conference - Simultaneous Surgery of Carotid Endarterectomy and Coronary Artery Bypass Graft
SHICHINOHE Hideo; HOUKIN Kiyohiro; KURODA Satoshi; ISHIKAWA Tatsuya; ABE Hiroshi; USHIKOSHI Satoshi; NUNOMURA Mitsuru; AIDA Toshimitsu; Hideo SHICHINOHE; Kiyohiro HOUKIN; Satoshi KURODA; Tatsuya ISHIKAWA; Hiroshi ABE; Satoshi USHIKOSHI; Mitsuru NUNOMURA; Toshimitsu AIDA; Departments of Neurosurgery Hokkaido University Graduate School of Medicine; Departments of Neurosurgery Hokkaido University Graduate School of Medicine; Departments of Neurosurgery Hokkaido University Graduate School of Medicine; Departments of Neurosurgery Hokkaido University Graduate School of Medicine; Departments of Neurosurgery Hokkaido University Graduate School of Medicine; Departments of Radiology Hokkaido University Graduate School of Medicine; Department of Neurosurgery Teine Keijinkai Hospital; Department of Neurosurgery Hakodate Central General Hospital, Surgery for Cerebral Stroke, 29, 4, 255, 261, 31 Jul. 2001
We review our 15 years of experience with patients with carotid artery stenosis to clarify the incidence of coronary artery disease. Of 197 patients who underwent carotid endarterectomy (CEA) since 1985, 16 (8.1%) had coronary artery disease that required treatment. Eleven patients could safely undergo staged treatments of CEA and coronary artery bypass graft (CABG)/percutaneous transluminal coronary angioplasty (PTCA). Four patients, however, underwent simultaneous CEA and CABG, because both carotid and coronary artery diseases were too serious for safe staged surgery.
We present the detailed medical records of these 4 cases. All had tight (more than 90%) stenosis of the internal carotid artery (ICA) and 2 or 3 branches of the coronary artery. They experienced TIA or minor completed stroke as well as unstable angina. One patient also presented chronic heart failure due to severe myocardial ischemia. We performed CEA and then CABG. Would closure was done after all surgical procedures to avoid bleeding due to intraoperative heparinization. Postoperative courses were uneventful in all 4 patients. We performed carotid stenting preceding simultaneous surgery with contralateral CEA and CABG for 1 patient who had bilateral severe carotid stenosis.
, The Japanese Society on Surgery for Cerebral Stroke, Japanese
- 医倫理学, 2024年, 博士後期課程, 医学研究科
- 基本医学総論, 2024年, 修士課程, 医学院
- 医倫理学序論, 2024年, 修士課程, 医学院
- 医学総論, 2024年, 博士後期課程, 医学院
- 医倫理学, 2024年, 博士後期課程, 医学院
- トランスレーショナルリサーチ概論, 2024年, 学士課程, 医学部
- Stem cell combined with scaffold for treating chronic cerebral hemorrhage
Grants-in-Aid for Scientific Research
01 Apr. 2020 - 31 Mar. 2023
川堀 真人; 七戸 秀夫
昨年度製法が確立したラット脳出血モデル(SDラットおよび免疫抑制ラット)に対して出血が吸収された2週後に出血腔内へのセルザイク投与(ラット由来およびヒト由来)を行い、その後1か月間の運動機能改善を評価した。またIn-vitroにおいてセルザイクとBMSCの栄養因子の分泌について評価した。In-vivoでセルザイク投与群の方がBMSC/生理食塩水より神経機能改善効果が有意に高く、脳萎縮率もCellSaic群で低い傾向であった。また、セルザイク投与群での血腫腔周囲の脳由来神経栄養因子(BDNF)量は生理食塩水群よりも有意に多く、BDNF抑制セルザイクは通常のセルザイクよりも神経機能改善の程度が小さかった。OGD環境では、CellSaicの方がBMSCより栄養因子分泌能および細胞増殖能が有意に高かった。
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 20K09382 - Development of neuroprotective therapy with selective intra-arterial infusion of cold artificial oxygen carrier
Grants-in-Aid for Scientific Research
01 Apr. 2016 - 31 Mar. 2019
Abumiya Takeo
A combination therapy of regional cold perfusion and HBOC administration was performed with a core-shell structured hemoglobin-albumin cluster “HemoAct” in rat transient middle cerebral artery occlusion model. The combination therapy was evaluated in comparison with a monotherapy of regional cold perfusion or HemoAct administration and an untreated control. In analysis of rats with 2-hour ischemia/24-hour reperfusion, combination therapy tended to be less in rCBF reduction and infarct volume. Durability of therapeutic effects of the combination therapy was confirmed till 7days after the treatment. Furthermore, the combination therapy ameliorated neurological disabilities and hemorrhagic transformation in rats with 4-hour and 5-hour ischemia/24-hour reperfusion. Because the therapeutic effects can be expected until 5 hours of ischemia and reperfusion, this therapy is a promising neuroprotective strategy in treatment of acute ischemic stroke.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 16K10708 - Elucidation of the pathology of spinal cord adhesive arachnoiditis and establishment of treatment
Grants-in-Aid for Scientific Research
01 Apr. 2015 - 31 Mar. 2018
SEKI Toshitaka
Spinal cord adhesive arachnoiditis causes chronic inflammatory changes in arachnoid membrane and pia mater tissue. As a result, spinal cord is failed chronicity progressively. Unfortunately, there is no established therapy for this disorder. It is not uncommon to recognize intractable neuropathic pain (np) due to this disorder, which severely impairs the patient's daily life. The purpose of this research was to establish a cure for intractable np due to spinal cord adhesive arachnoiditis after spinal cord injury. We decided to prepare stable animal experimental model of spinal cord injury before this experiment. Since modified cerebral aneurysm clips for existing animal spinal cord injuries were expensive and difficult to carry out ongoing experiments, we requested Japanese companies to manufacture a anew modified aneurysm clip. We could create a spinal cord injury model using a new clip , and there was no statistically significant difference compared with existing animal model.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 15K10552 - Investigation of barrier function of endothelial cells derived from moyamoya disease-specific iPS cells
Grants-in-Aid for Scientific Research
01 Apr. 2015 - 31 Mar. 2018
KAZUMATA Ken
We differentiated vascular endothelial cells from iPS cells derived from healthy persons and moyamoya disease patients. The expression of cell junction related genes were analysed with microarray and the result showed that CLDN1, DST, NEXN and ITGB3 were down-regulated in moyamoya disease. RT-PCR showed that ITGB3 was significantly downregulated in moyamoya disease, however, there were no significat difference in the expression of DST and NEXN. We could not observe the band intensity of CLDN1 in neither RT-PCR and western blotting. In permeability assay, permeability was increased in endothelial cells of moyamoya disease when Y-27632 was added to medium, whereas permeability decreased in normal control.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 15K10286 - Can inflammation worsen the prognosis of severe subarachnoid hemorrhage
Grants-in-Aid for Scientific Research
01 Apr. 2015 - 31 Mar. 2018
HOKARI Masaaki
Inflammation process following severe subarachnoid hemorrhage may exacerbate neuronal damage. Recent studies have revealed that microglia may play an important role in brain inflammation after cerebral damage, however the role of microglia after subarachnoid hemorrhage is not well understood. The authors have conducted a basic research to figure out whether hypothermia and minocycline which is the suppresive drug of microglia will work against inflammation after subarachnoid hemorrhage.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 15K10284 - Nuclear medicine imaging toward therapeutic strategy of atherosclerosis: Experimental research to establish EBM
Grants-in-Aid for Scientific Research
01 Apr. 2014 - 31 Mar. 2018
KUGE Yuji
The results obtained by our research are as follows.
(1) An automated synthesis method for 18F-RGD-K5 (an integrin αvβ3 imaging agent) has been successfully established. (2) Unlike 18F-FDG, 18F-FMISO (an hypoxia imaging agent) was found to accumulate in M2 macrophages present in hypoxic environment. (3) It was also confirmed that 2-nitroimidazole compounds selectively accumulated in the atherosclerotic regions of a rabbit model.
These results would contribute to establish diagnostic imaging of atherosclerosis.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (B), Hokkaido University, 26293268 - Induction of smooth muscle cells from iPS cells derived from moyamoya disease patient
Grants-in-Aid for Scientific Research
01 Apr. 2015 - 31 Mar. 2017
Houkin Kiyohiro
To investigate the pathogenesis of moyamoya disease, we induced smooth muscle cells from iPS cells derived from moyamoya disease patients. First, we induced neural crest cells from iPS cells. We found more than 99% of the cells were positive for p75. Next we differentiated these neural crest cells into smooth muscle cells, however, the cells become senescent during differentiation. Although surviving cells were almost positive for α-SMA and SM22, these cells could not be used for next analysis because of cell senescence. Improvement of the protocol is necessary to prevent cell senescence in the future.
Japan Society for the Promotion of Science, Grant-in-Aid for Challenging Exploratory Research, Hokkaido University, 15K15520 - Genome-wide CNV array analysis in parent-offspring pairs with Moyamoya disease with and without clinical anticipation
Grants-in-Aid for Scientific Research
01 Apr. 2013 - 31 Mar. 2016
Yoshimoto Tetsuyuki; NAKAYAMA NAOKI; KAZUMATA KEN; SHICHINOHE HIDEO; HOUKIN KIYOHIRO; SASAKI HIDENAO; ITO MASAKI
Copy Number Variation (CNV) defining a DNA segment 100 kilobases or larger in size and present at variable copy numbers in comparison with a reference genome were investigated in unbiased 15 parent-offspring pairs with Moyamoya disease (MMD). Clinical anticipation, defining that pediatric patient(s) were born from adult-onset parent(s), was confirmed in 10 pairs. Genome-wide CNV array analysis detected 211 CNV loci throughout the genome except for chr.21. Of these, overlapping CNV loci for more than 3 individuals were seen in 10 segments in autosomes. CNV in a region of chr16p13.3 was a unique locus, in which copy number state between each parent and offspring pairs varied. Notably for this CNV, copy number gain was observed in the offspring with anticipation compared to the parents. Copy number gain on chr16p13.3, containing 14 genes, may contribute to the anticipation of familial MMD by altering gene dosage in variable possible forms, although further validation is necessary.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 25462203 - The role of SIRT1 in cellular senescence and characteristics in brain microvascular endothelial cells
Grants-in-Aid for Scientific Research
01 Apr. 2013 - 31 Mar. 2015
HOUKIN Kiyohiro; NAKAYAMA Naoki; KAZUMATA Ken; ABUMIYA Takeo; SHICHINOHE Hideo
The present study was performed with cultured senescent bovine brain endothelial cells (BMEC) with high passage numbers. P15-20 senescent BMEC contained giant cells with increase of β-galactosidase activity and reactive oxygen species. In comparison between P5 BMEC and P 15 BMEC subjected to oxygen-glucose deprivation and reoxygenation, P15 BMEC showed significantly more cell death and apoptosis. P5 BMEC showed significantly more induction of SIRT1 expression. This result suggests that SIRT1 seems to have cellular protective effects and lose its capacity of induction in senescent cells.
Japan Society for the Promotion of Science, Grant-in-Aid for Challenging Exploratory Research, Hokkaido University, 25670612 - Analysis for circulating endothelial progenitor cells in moyamoya disease
Grants-in-Aid for Scientific Research
01 Apr. 2012 - 31 Mar. 2015
HOUKIN Kiyohiro; KURODA Satoshi; SHICHINOHE Hideo
1) Consumption of circulating EPC in MMD patients: Thirty-three patients with MMD and 14 healthy volunteers were registered to obtain mononuclear cells and plasma. In the patients, the circulating EPC was lower than control, and the circulating CD133+/CD34+ cells decreased after the operation, significantly. The level of bFGF was significantly lower in adult patients. The results suggested that EPCs would be consumed aggressively at the lesion. The pathological significance of bFGF in adult patients is still unclear.
2) Analysis of iPS cells from MMD patients: The iPS cell lines were established from PBMNCs of 3 MMD patients and 3 healthy persons. The endothelial differentiation was conducted on matrigel layer. The endothelial cells from MMD were impaired for the angiogenesis in vitro, significantly. In microarray analysis, it was found that KEGG pathway analysis of genes downregulated in MMD, that is, extracellular matrix receptor-related genes were significantly downregulated in MMD.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (B), Hokkaido University, 24390336 - Autologous Bone Marrow Stromal Cell Transplantation for Stroke: Steps to Standardize the Clinical Protocols
Grants-in-Aid for Scientific Research
2011 - 2012
SHICHINOHE Hideo; HOUKIN Kiyohiro; KURODA Satoshi
Human bone marrow stromal cells (BMSCs) were cultured with human platelet lysate (hPL) instead of fetal calf serum (FCS). Their production of growth factors was quantified with ELISA. The BMSCs were labeled with superparamagnetic iron oxide (SPIO). Rat permanent focal ischemia models were made and BMSCs were injected into the ipsilateral striatum 7 days post-insult. There was no difference in cell proliferation between the BMSCs cultured with hPL and FCS. The BMSC-hPL produced not less amount of BDNF, HGF, NGF, PDGF-BB and TGF-beta1. Rotarod test showed that the motor function deteriorated after ischemia and BMSC transplantation enhanced the recovery. MRI demonstrated that the SPIO-BMSCs migrated towards the lesion. 18F-FDG PET showed that the recovery of glucose utilization was promoted. The hPL may be valuable and safe in expanding BMSCs. The application of bio-imaging techniques are also valuable for BMSC transplantation against stroke.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (B), Hokkaido University, Principal investigator, Competitive research funding, 23390342 - Comprehensive strategy for neuronal regenerative medicine with human bone marrow stromal cells (BMSC) transplantation
Grants-in-Aid for Scientific Research
2009 - 2011
KURODA Satoshi; HIDA Kazutoshi; KOBAYASHI Hiroyuki; SHICHINOHE Hideo
In our present research, we aimed to translate the regenerative medicine with human bone marrow stromal cells (BMSC) to the central nervous system disorders. The results were as follows; (1) When the old rat BMSC were cultured with G-CSF (granulocyte-colony stimulating factor), the cellular activity could be stimulated. (2) The addition of human platelet lysate (PL) was useful for the animal serum-free cell culture. (3) The scaffold with fibrin matrix or TGP hydrogel was useful as a cell delivery system to the lesion. (4) The behavior of the transplanted BMSC could be monitored temporally and noninvasively using the optical imaging or MRI. (5) The nuclear medicine imaging was useful to evaluate the neural repair after cell transplantation.
Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (B), Hokkaido University, Coinvestigator not use grants, Competitive research funding, 21390400 - Human bone marrow stromal cells transplantation to regenerate central nervous system ; The translational research with novel technologies.
Grants-in-Aid for Scientific Research(基盤研究(B))
2008 - 2010
Hideo SHICHINOHE; 矢野 俊介; Satoshi KURODA; Yoshinobu IWASAKI; Kazutoshi HIDA; Hiroyuki KOBAYASHI
This study was aimed to translate the regenerative medicine with human bone marrow stromal cells (BMSC) to the central nervous system disorders. The results were as follows; (1) the BMSC could be cultured with some bio-matrixes. (2) The addition of G-CSF (granulocyte-colony stimulating factor) to the culture medium could stimulate the cellular activity of the BMSC. On the other hand, the addition of human platelet lysate (PL) was useful for the animal serum-free cell culture. (3) The scaffold with fibrin matrix or Mebiol gelR was useful as a cell delivery system to the lesion. (4) The behav...
Ministry of Education, Culture, Sports, Science and Technology, 基盤研究(B), 北海道大学, Principal investigator, Competitive research funding, 20390377 - Translational Research for Clinical Application of Autologous Bone Marrow Stromal Cell Transplantation for CNS disorders
Grants-in-Aid for Scientific Research(基盤研究(C))
2008 - 2010
矢野 俊介; Kazutoshi HIDA; Satoshi KURODA; Hideo SHICHINOHE; Yoshinobu IWASAKI
For these 3 years, we have run many experiments and explored many new knowledge on autologous bone marrow stromal cell transplantation for central nervous system disorders. We have reported the novel aspects of their biological features and the utility of bioimaging technology such as MRI and optical imaging. This report shows the brief summary of these knowledge.
Ministry of Education, Culture, Sports, Science and Technology, 基盤研究(C), 北海道大学, Coinvestigator not use grants, Competitive research funding, 20591701 - COMPREHENSIVE RESEARCH PROJECT FOR CENTRAL NERVOUS SYSTEM REGENERATION BY BONE MARROW STROMAL CELL TRANSPLANTATION
Grants-in-Aid for Scientific Research(基盤研究(B))
2005 - 2007
Kazutoshi HIDA; 七戸 秀夫; 黒田 敏; 岩崎 喜信; 矢野 俊介; 小林 浩之; 中山 若樹
We isolated the BMSC from the green fluorescence protein (GFP)-transgenic mice and transplanted them into the mice subjected to spinal cord injury. We could visualize the transplanted cells through the dura mater in the living animals for 4 weeks after transplantation, using a novel fluorescence imaging technique. These data were published in J Neurotrauma (2005). Furthermore, we have confirmed that the transplanted BMSC could improve the GABA receptor function around cerebral infarction and spinal cord injury, using autoradiography and fluorescence immunostaining. These data were published...
Ministry of Education, Culture, Sports, Science and Technology, 基盤研究(B), 北海道大学, Coinvestigator not use grants, Competitive research funding, 17390389 - RESEARCH FOR BONE MARROW STROMAL CELLS (BMSC) TRANSPLANTATION THERAPY FOR INJURED CENTRAL NERVOUS SYSTEM FOCUSED ON AXON EXTENSION FROM THE HOST NEURONS
Grants-in-Aid for Scientific Research(基盤研究(C))
2005 - 2006
七戸 秀夫; H. KOBAYASHI; 小林 浩之; 黒田 敏; 飛騨 一利; 矢野 俊介; 岩崎 喜信; 菊地 誠志
We isolated the BMSC from the green fluorescence protein (GFP)-transgenic mice and transplanted them into the mice subjected to spinal cord injury. We could visualize the transplanted cells through the dura mater in the living animals for 4 weeks after transplantation, using a novel fluorescence imaging technique. These data were published in J Neurotrauma (2005). Furthermore, we have confirmed that the transplanted BMSC could improve the GABA receptor function around cerebral infarction and spinal cord injury, using autoradiography and fluorescence immunostaining. These data were published...
Ministry of Education, Culture, Sports, Science and Technology, 基盤研究(C), 北海道大学, Principal investigator, Competitive research funding, 17591496 - 自己骨髄細胞を利用したもやもや病に対する血管新生療法の開発
科学研究費補助金(萌芽研究)
2005 - 2006
岩崎 喜信; 七戸 秀夫; 鐙谷 武雄; 石川 達哉; 黒田 敏; 中山 若樹
マウス脳梗塞モデル、および、ラット脊髄損傷モデルに骨髄間質細胞(bone marrow stromal cell; BMSC)を定位的に移植すると、BMSCが病変周囲に遊走して神経細胞特有の表現型を獲得するのみならず、神経細胞にのみ存在する受容体の機能を獲得して、脳梗塞や脊髄損傷周囲における受容体機能を改善させることを明らかとした。これらの結果は、それぞれJ Nucl Med誌(2006)、J Neurotrauma誌(2006)に掲載された。BMSCが神経細胞に分化する際の分子生物学的背景を明らかにする目的で、培養BMSCのマイクロアレイ解析を実施した。その結果、BMSCは神経細胞への分化誘導によって、その遺伝子表現型を変化させることが判明した。この結果はBrain Res誌(2006)に掲載された。BMSCが病変周囲に遊走するためには病変周囲で産生されるSDF-1、および、BMSCの膜表面に存在するSDF-1に特異的受容体であるCXCR4が必須の役割を果たしていることを、CXCR4ノックアウトマウスを用いた実験を実施することで明らかとした。現在、J Cereb Blood Flow Metab誌に投稿中である。BMSCと神経細胞の共培養実験系を確立した。この実験系を活用することにより、BMSCの一部が神経細胞そのものへ分化すること、一部は神経細胞と細胞融合することを初めて...
文部科学省, 萌芽研究, 北海道大学, Coinvestigator not use grants, Competitive research funding, 17659437 - A basic study of gene and anti-angiogenic therapy for malignant brain tumor using bone marrow stromal cell and its potential of cell-fusion
Grants-in-Aid for Scientific Research(基盤研究(B))
2004 - 2006
石井 伸明; Yoshinobu IWASAKI; 岩崎 喜信; 小林 浩之; 黒田 敏; 七戸 秀夫; 矢野 俊介; 吉野 雅美
1. We have established the culture system of the bone marrow stromal cells (BMSC) obtained from the rats and mice. FACS analysis showed BMSCs expressed CD34 (-), CD45 (+/-), CD90 (+) and Sca1 (+). These data were published in Brain Res Protoc (2004).2. The BMSCs presented active cell proliferation when it was transplanted into infarct brain. These data were published in Brain Res (2005).3. Gene expression profiling was performed for cultured BMSCs and it was clarified that the BMSCs had potentials to alter their gene expression patterns in response to external stimuli. The data were publish...
Ministry of Education, Culture, Sports, Science and Technology, 基盤研究(B), 北海道大学, Coinvestigator not use grants, Competitive research funding, 16390401 - RESEARCH FOR BONE MARROW STROMAL CELLS (BMSC) TRANSPLANTATION THERAPY FOR INJURED CENTRAL NERVOUS SYSTEM USING BIOMATERIALS AND GENE ANALYSIS
Grants-in-Aid for Scientific Research(基盤研究(B))
2003 - 2005
Yoshinobu IWASAKI; 関 俊隆; 池田 潤; 小林 浩之; 黒田 敏; 七戸 秀夫; 飛騨 一利; 田村 守; 矢野 俊介
We have established the culture system of the bone marrow stromal cells (BMSC) obtained from the rats and mice, and transplanted them into the animals subjected to cerebral infarction or spinal cord injury. These data were published in Neuropathology (2003) and Brain Res Protoc (2004). We isolated the BMSC from the green fluorescence protein (GFP)-transgenic mice and transplanted them into the mice subjected to cerebral infarction or spinal cord injury. We could visualize the transplanted cells through the skull or the dura mater in the living animals, using a novel fluorescence imaging tec...
Ministry of Education, Culture, Sports, Science and Technology, 基盤研究(B), 北海道大学, Coinvestigator not use grants, Competitive research funding, 15390426 - RESEARCH FOR CELL TRANSPLANTATION THERAPY FOR CEREBRAL INFARCTION AND SPINAL CORD INJURY USING BONE MARROW STROMAL CELLS (BMSC)
Grants-in-Aid for Scientific Research(基盤研究(B))
2002 - 2005
Satoshi KURODA; 飛騨 一利; 田村 守; 澤田 賢一; 池田 潤; 多田 光宏; 矢野 俊介; 関 俊隆; 七戸 秀夫; 岩崎 喜信; 飛騨 一利; 田村 守
We have established the culture system of the bone marrow stromal cells (BMSC) obtained from the rats and mice, and transplanted them into the animals subjected to cerebral infarction or spinal cord injury. These data were published in Neuropathology (2003) and Brain Res Protoc (2004). We isolated the BMSC from the green fluorescence protein (GFP)-transgenic mice and transplanted them into the mice subjected to cerebral infarction or spinal cord injury. We could visualize the transplanted cells through the skull or the dura mater in the living animals, using a novel fluorescence imaging tec...
Ministry of Education, Culture, Sports, Science and Technology, 基盤研究(B), 北海道大学, Coinvestigator not use grants, Competitive research funding, 14370424
